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Inhibition of arterial KDR channels by DPO-1 and activation of cloned human BK 
channels by BPA-MS 
 
Ibra S. Fancher IV 
 
The following documents our attempt at answering a fundamental question in vascular 
smooth muscle: Which K+ channels control membrane potential, and thus, vascular 
tone? A number of groups have approached this question and great strides have been 
made; however, uncertainty remains as to which specific K+ channel(s) underlies this 
physiologically important current. Previous studies using nonselective pharmacological 
inhibitors of voltage-dependent K+ (KV) channels, particularly delayed rectifier K
+ (KDR) 
channels, indicate membrane depolarization, Ca2+ influx, and vasoconstriction. 
Importantly, however, there are more than 40 genes known to encode KV channel 
subunits. We hypothesize that KDR channels composed of KV1 subunits are responsible 
for the polarizing current of arterial smooth muscle. Recently, diphenyl phosphine oxide-
1 (DPO-1) has been suggested as a specific KV1.5 inhibitor. Therefore, we used DPO-1 
as a pharmacological tool to investigate the role of KV1.5 subunits in the KDR channels 
of arterial smooth muscle. In Chapter 2, we tested the specificity of DPO-1 for KV1.5 
using KV1.5 knockout (KO) mice. Whole-cell patch clamp recordings revealed reduced 
current and less percent block by DPO-1 in aortic smooth muscle cells from KO mice. 
Additionally, in Chapter 2, we determined that resistance vessels from rat brain and 
skeletal muscle contain a DPO-1-sensitive KDR current, constrict in response to DPO-1, 
and these KDR channels control reactivity. In Chapter 3, we investigated the mechanism 
of block by DPO-1 of KDR channels in porcine coronary smooth muscle cells and found 
that it was largely similar to that known for cloned KV1.5 channels. Together this work 
suggests that KV1.5 is a major contributor to the KDR current observed in arterial smooth 
muscle across a number of species and in a variety of arterial vessel types. 
Furthermore, these DPO-1-sensitive KDR channels regulate vascular tone, buffer 
vasoconstriction, and control reactivity. An additional interest of our group, and 
incorporated into the body of this document as Chapter 4, is the effects of the 
xenoestrogenic endocrine disruptor bisphenol A (BPA). We have previously shown that 
BPA activates large conductance voltage- and Ca2+-activated K+ (BK) channels and 
here we build on this knowledge by examining which side of the cell membrane BPA 
mediates the activity of BK. This was done by formation of a membrane impermeable 
BPA-monosulfate (BPA-MS) and subsequent electrophysiological experiments 
determined that BPA may have both intracellular and extracellular binding sites on the 
β1 auxiliary subunit. Collectively, this dissertation is an investigation of the physiology 
and pharmacology of K+ channels with respect to an underlying interest in vascular 
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Introduction to KV1 Channels in the Vasculature 
 
Voltage-dependent K+ (KV) channels are expressed in excitable tissues including 
skeletal and cardiac muscle. While KV channels are expressed in vascular smooth 
muscle, their role in regulating membrane potential and tone remains debated. 
Convincing data suggests KV1 channel members, possibly in heterologous 
conformations (e.g., KV1.2-1.5 heteromultimers), are responsible for the physiologically 
important delayed rectifier K+ (KDR) current. However, evidence also exists for Ca
2+-
activated K+ channels, ATP-dependent K+ channels, and other KV channels including 
the recently popular KV7 channels. Which channel(s) is/are responsible for regulating 
membrane potential and tone? In the following review of the literature, the K+ channels 
that may regulate membrane potential and tone will be discussed and an argument will 
be made for KV1 channels, specifically KV1.5. Finally, the present knowledge gap with 
relation to health and disease will be discussed and the significance of the current body 
of work will be addressed.  
 
Regulators of membrane potential and tone: A variety of K+ channels in vascular 
smooth muscle  
 The electrochemical gradient for K+ is arranged such that high concentration of K+ 
inside the cell exits through K+-permeable ion channels embedded in the otherwise 
lipophilic cell membrane. The K+ current (IK) is essential for setting the polarized 
membrane potential and IK is therefore responsible for maintaining vascular tone such 
that vasoconstriction or vasodilation is possible. The membrane potential of arterial 
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vascular smooth muscle, at approximately -50 mV, is essential for controlling Ca2+ entry 
therefore physiological mechanisms of vascular reactivity which ultimately regulate 
tissue perfusion and pressure within the organism. Figure 1.1 is a cartoon depicting the 
cellular mechanisms that set resting membrane potential and thereby control arterial 
tone. While these physiological mechanisms have been intensely investigated and are 
well documented, the specific K+ channels responsible for resting tone in arterial 
vascular beds remain elusive. This section will discuss the possible candidates, many of 
which have been reviewed previously (Jackson, 1998, 2000). 
 Figure 1.2 is a cartoon representing the K+ channels expressed in arterial smooth 
muscle including those hypothesized to control arterial tone at rest. A number of Ca2+-
activated K+ channels have been implicated as having a role in arterial tone, including 
small and intermediate Ca2+-activated K+ channels (SK and IK, respectively) and the 
large voltage-dependent Ca2+-activated K+ channel (BK). In cerebral arteries, Ca2+-
activated K+ channel blockers depolarized and constricted vessels at concentrations 
that were previously shown to inhibit channel current directly; an effect that was reduced 
with low intracellular Ca2+ or by blocking Ca2+ channels (Brayden & Nelson, 1992; Miller, 
1988). However, this effect has also been reported as specific to the brain stem basilar 
artery and absent in middle cerebral artery (Horiuchi, Dietrich, Tsugane, & Dacey, 
2001). BK has been given great attention because of its physiological agonists, voltage 
and Ca2+, and would thus appear to participate in a negative feedback loop regulating 
myogenic tone in small arteries (Jackson & Blair, 1998). However, a paradoxical role for 
Ca2+ in promoting vasodilation by activating BK via Ca2+ sparks from ryanodine 
receptors (RyR) has been shown to regulate membrane potential and arterial tone in 
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cerebral arteries as evidenced by iberiotoxin- (BK channel blocker) and ryanodine-
induced membrane depolarization and vasoconstriction (Knot, Standen, & Nelson, 
1998). Recently, this mechanism has been shown to be exclusive to cerebral pial 
arteries vs. parenchymal arteries depending on physiological pH, suggesting that even 
vessels of the same arcade may have different K+ channel regulators of arterial tone 
(Dabertrand, Nelson, & Brayden, 2013). To complicate matters further, the auxiliary β1 
subunit, which increases the sensitivity of BK channels to Ca2+ and voltage and is 
physically associated with the BK α pore of vascular smooth muscle, has been the 
subject of conflicting reports concerning the role of BK channels in arterial tone. One 
such study using a BK β1 deficient mouse reports increased blood pressure due to an 
uncoupled BK/Ca2+ spark mechanism, while another study indicates that the elevated 
blood pressure in BK β1 deficient mice is background-dependent and due to changes in 
aldosterone levels (Pluger et al., 2000; Sachse, Faulhaber, Seniuk, Ehmke, & Pongs, 
2014). 
 While it remains a possibility that BK, SK, and IK channels could regulate arterial 
tone in a few distinct vascular beds or in some species, it appears to be more likely that 
activation of BK is indicative of a hyperpolarizing brake upon vasoconstriction. For 
instance, in the cremaster arterioles of hamster and rat, as well as rat cerebral 
arterioles, BK has also been found to be silent at rest; arteriolar diameter and whole-cell 
IK from isolated smooth muscle cells was not influenced by iberiotoxin or 
tetraethylammonium (TEA) (Jackson & Blair, 1998; Jackson, Huebner, & Rusch, 1997; 
Loeb, Godeny, & Longnecker, 2000; Paterno, Faraci, & Heistad, 1996). The idea that 
BK channels regulate arterial tone can also be challenged with the notion that many 
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endogenous vasoactive modulators have been shown to tightly regulate Ca2+ spark 
frequency and amplitude and could then affect BK channel activity in a manner not 
suitable for maintaining vascular tone, rather a seemingly more suitable mechanism to 
promote vasoconstriction or –dilation (Jaggar, Stevenson, & Nelson, 1998; Jaggar, 
Wellman, et al., 1998; Porter et al., 1998). A possibly more convincing contradiction to 
the hypothesis that BK governs arterial tone is that the open probability of BK in the 
potentials of arterial smooth muscle cells at rest should be very low, and intracellular 
Ca2+ would be in sub-micromolar ranges (Jackson & Blair, 1998). Furthermore, the 
elevated expression of BK in models of hypertension, reviewed by Rusch and Liu, is 
suggestive of a negative feedback to membrane depolarization, elevated intracellular 
Ca2+, and ultimately increased myogenic tone (M. Asano, Masuzawa-Ito, & Matsuda, 
1993; M. Asano, Matsuda, Hayakawa, Ito, & Ito, 1993; Rusch & Liu, 1997). While BK 
channels, and therefore Ca2+ and membrane potential, may have a role in arterial tone 
in some vascular beds, metabolic regulation of K+ channels has also been investigated. 
 ATP-dependent K+ channels (KATP) are inhibited by ATP and have also been 
implicated in regulating arterial tone. KATP channels have been extensively reviewed 
(Brayden, 2002; Quayle, Nelson, & Standen, 1997). The proposed molecular makeup of 
these channels in human vascular smooth muscle has been shown to be the weakly 
inwardly rectifying pore Kir6.1 and the ATP-binding auxiliary sulfonylurea receptor 
subunit SUR2B as evidenced by transcript expression in pulmonary artery smooth 
muscle (Cui, Tran, Tinker, & Clapp, 2002). Deletion of the Kir6.1 subunit in the smooth 
muscle of mice rendered the mice hypertensive and KATP agonists such as pinacidil 
failed to induce vasodilation, perhaps indicating that KATP regulates arterial tone at rest 
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(Aziz et al., 2014). In addition, the KATP channel blocker glibenclamide constricted 
hamster cheek pouch microvessels at rest and abolished vasodilatory actions of 
pinacidil and cromakalim (Jackson, 1993). Furthermore, the resting membrane potential 
of single smooth muscle cells isolated from rat and hamster depolarized with application 
of glibenclamide (Jackson et al., 1997). Glibenclamide also increased basal phrenic 
resistance in an in vivo anesthetized dog model while it also reduced baseline blood 
flow in the calf of human subjects, further supporting that KATP regulates arterial tone at 
rest (Kosmas, Levy, & Hussain, 1995; Vanelli & Hussain, 1994).  
 While a growing body of literature shows that blockade of KATP constricts vessels at 
rest, including the systemic, coronary, mesenteric, pulmonary, and renal circulations, 
evidence too exists that it plays no role in some of these same vascular beds (Comtois, 
Sinderby, Comtois, Grassino, & Renaud, 1994; Gardiner, Kemp, March, Fallgren, & 
Bennett, 1996; Jackson, 1993; Moreau et al., 1994; Parekh & Zou, 1996). In studies 
investigating the skeletal muscle and pulmonary vasculature of dogs and cats, neither 
glibenclamide nor a non-sulphonylurea (U378838) KATP blocker had an effect on 
baseline arterial flow or resistance (DeWitt et al., 1996; Lippton et al., 1995). In fact, 
numerous animal models have failed to show any connection to KATP in resting arterial 
tone in the pulmonary circulation (DeWitt et al., 1996; Duncker, Oei, Hu, Stubenitsky, & 
Verdouw, 2001; Hasunuma, Rodman, & McMurtry, 1991; Lippton et al., 1995). 
Furthermore, KATP is expressed and functional throughout the cerebral vasculature, yet 
no role has been suggested for the channel in regulating resting arterial tone (Faraci & 
Heistad, 1998). Glibenclamide alone failed to constrict basilar arteries or cerebral 
arterioles in a variety of in vivo studies and only prevented vasodilation in the presence 
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of KATP agonists (Bari, Errico, Louis, & Busija, 1996; Faraci & Heistad, 1993; Kitazono, 
Faraci, & Heistad, 1993; Lang, Paterno, Faraci, & Heistad, 1997; Wahl, Parsons, & 
Schilling, 1994). Similarly to the Ca2+-activated K+ channels, KATP may play a role in 
regulating arterial tone at rest in specific vascular beds of certain species, but probably 
plays a more important role in coupling metabolic cues to blood flow, thus promoting 
vasodilation when oxygen tension decreases.  
 The superfamily of voltage-dependent K+ channels (KV), are activated by membrane 
depolarization at potentials positive to -50 mV and are therefore popular candidates for 
regulating resting arterial membrane potential and tone. This is a diverse family of K+ 
channels almost ubiquitously blocked by 4-aminopyridine (4-AP) and many members 
are expressed in arterial smooth muscle (Figures 1.2 and 1.3). Application of 4-AP 
depolarized membrane potential and increased intracellular Ca2+ in isolated arterial 
smooth muscle cells of dog and hamster (Dick et al., 2008; Jackson et al., 1997). 4-AP 
also reduced resting coronary flow in an in vivo dog model, suggesting that KV channels 
are responsible for coronary arterial tone (Dick et al., 2008). In rabbit cerebral arteries, 
4-AP depolarized isolated smooth muscle cells and reduced vessel diameters; an effect 
that was not prevented by prior additions of numerous other K+ channel blockers, 
suggesting that KV channels alone regulate cerebral arterial resting tone (Knot & 
Nelson, 1995). Furthermore, 4-AP blockade of KV channels constricted both the basilar 
and middle cerebral arteries of rats (Horiuchi et al., 2001). While evidence for KV 
channels in regulating resting arterial tone exists across numerous vascular beds in a 
variety of species, the lack of specificity with 4-AP does not allow for the identification of 
particular KV channels that may contribute.  
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 A few subfamilies have been most investigated and include the KV1s and, more 
recently, the KV7s. The KV7 channel blockers linopirdine and XE991 have been shown 
to produce both membrane depolarization and vasoconstriction at rest (Joshi, Balan, & 
Gurney, 2006; Yeung & Greenwood, 2005). Furthermore, the effect on arterial reactivity 
was abolished by L-type Ca2+ channel block, indicating the necessary mechanisms of 
membrane depolarization and intracellular Ca2+ in vasoconstriction upon KV7 blockade 
(Joshi et al., 2006). Interestingly, KV7.1 blockers alone could not constrict 
intrapulmonary arteries yet KV7.1 activators relaxed arteries and linopirdine induced 
constrictions, indicating the presence of KV7.1 in vascular smooth muscle without a role 
in arterial tone (Madeley, 1988). A functional heterotetrameric assembly has been 
proposed and may consist of KV7.1 and KV7.5 subunits, diversifying vascular smooth 
muscle channels and complicating physiological and pharmacological approaches 
(Oliveras et al., 2014). Negative data regarding a role for the KV7s is sparse, however, 
preliminary data show that neither linopiridine nor flupirtine have an effect on resting or 
metabolic coronary flow during in vivo, open chest experiments in swine (Goodwill et al., 
2013). In addition, neither flupirtine nor retigabine have produced the predicted effects 
in isolated arterial smooth muscle cells from pig right coronary artery or rat aorta in our 
own investigations (unpublished observations). However, others and we claim that the 
KV1 subfamily plays a critical role in resting arterial tone and that further investigation of 
this group, as well as its specific members, should be entertained. An introduction to the 
KV1 subfamily and a putative role in arterial tone and reactivity follows. 
 
KV1 channels, membrane potential, and resting tone 
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 KV1 channels arise from the KCNA Shaker family of genes and are expressed in a 
variety of excitable and non-excitable cells. In excitable cells, such as neurons and 
cardiac muscle, these channels have been associated with repolarizing currents 
following membrane depolarization during the action potential (Murray et al., 1994; 
Rowan, Tranquil, & Christie, 2014). The role of KV1 channels in many non-excitable 
cells, including vascular smooth muscle, is still under investigation. Recent evidence 
has suggested roles in inflammation and cell division of cancer cells, thus implicating 
KV1 channels as possible therapeutic targets in some disease states (Comes et al., 
2013; Koch Hansen et al., 2014; Koeberle & Schlichter, 2010).  
 KV1 channels are comprised of four membrane-spanning proteins that together 
make a functional ion channel selective for K+ flux. Each protein of the subfamily has six 
transmembrane segments: S1-S4 represents the voltage-sensitive domains, with S4 
being the voltage sensor containing positively charged arginine and lysine residues. The 
S5 and S6 segments form the pore domain for the selectivity and conductance of K+ 
(Aggarwal & MacKinnon, 1996; Long, Campbell, & Mackinnon, 2005; Seoh, Sigg, 
Papazian, & Bezanilla, 1996). Each of the four voltage-sensing domains must react to 
membrane depolarization for the channels to activate (open). The KDR current from KV1 
channels displays unique kinetics due to, in most members of the subfamily, an N-type 
gating mechanism (Prince & Pfaffinger, 2013). KDR kinetic properties are such that while 
in the presence of the continued depolarization, the open channels inactivate (one type 
of closure) in a time-dependent manner. KV1 channels deactivate (another type of 
closure) when the stimulus is removed during repolarization. Figure 1.4 shows example 
traces of whole-cell patch clamp recordings from porcine coronary smooth muscle cells.  
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KDR current is shown during depolarization to +20 mV in A) ‘short’ and B) ‘long’ pulse 
protocols. Activation and deactivation are readily appreciated from the ‘short’ pulse, 
while inactivation is more clearly demonstrated in ‘long’ pulse. Regulatory subunits, 
endogenous proteins and physiological molecules, and drugs can affect KV1 channel 
activity and kinetics. Mechanisms of drug block, i.e. during which channel state (open or 
closed) the drug is binding and therefore inhibiting KDR, are useful ways to study KDR 
currents.  
  The role of KV1 channels in resting arterial tone remains unclear, however, some 
reports indicate that KDR from KV1 channels sets resting membrane potential. Previous 
work conducted by my mentor shows that correolide (KV1 specific antagonist)-sensitive 
KV channels make up a significant portion of the total KDR population in canine coronary 
smooth muscle, and that this KDR is responsible for resting arterial tone and membrane 
potential (Dick et al., 2008). Others have reported that the 4-AP-sensitive KDR is 
attributed to KV1 channels by comparison of native cells to that of cloned KV1 
expression systems (Clement-Chomienne, Ishii, Walsh, & Cole, 1999; Grissmer et al., 
1994; Kerr et al., 2001; Po, Roberds, Snyders, Tamkun, & Bennett, 1993). In one such 
report, rabbit vascular smooth muscle cell KDR was similar to a cloned complex of KV1.2 
and KV1.5 indicating this KV1 channel conformation could be the dominant form of the 4-
AP-sensitive KV channel population in vascular smooth muscle (Kerr et al., 2001). 
Molecular analyses from numerous groups have revealed a number of KV1 transcripts 
and proteins in a variety of vascular smooth muscle from different species and a few 
reports support the formation of heterotetrameric conformations (Albarwani et al., 2003; 
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Archer et al., 1998; Cheong, Dedman, & Beech, 2001; Cheong, Dedman, Xu, & Beech, 
2001; Kerr et al., 2001; Plane et al., 2005; Po et al., 1993; Thorneloe et al., 2001). 
 The identification of KV1 heterotetramers may underlie the differences observed with 
drug effects in native cells versus cloned KV1 homotetramers, yet the lack of KV1 
member-specific inhibitors has limited the field in delineating the true molecular identity 
of native KDR in arterial smooth muscle. Recently, however, diphenyl phosphine oxide-1 
(DPO-1) was synthesized and proposed as a KV1.5 specific inhibitor. Fortunately, this 
specific KV1 member has been implicated by a number of previous studies and 
therefore further examination of DPO-1 is warranted. In the following section, the 
studies that have investigated a role in arterial tone and reactivity specifically for KV1.5 
will be addressed as will a rationale to use DPO-1 to further investigate the molecular 
identity of native KDR.  
  
Evidence for an integral role for KV1.5 
 
 As discussed in the previous section pertaining KV1 subfamily topology and 
assembly, KV1.5 proteins contain six transmembrane segments with S4 being the 
prominent voltage sensor (Figure 1.5 A). Assembly is such that four KV1.5 proteins 
make a functional ion channel, with regulatory N-terminal T1 domains from each protein 
self-tetramerizing within the cell (Figure 1.5 B) (Pfaffinger & DeRubeis, 1995). KV1.5 
exhibits ultra-rapid fast activation and slow inactivation KDR kinetics (Feng, Wible, Li, 
Wang, & Nattel, 1997; Feng, Xu, Wang, & Nattel, 1998). The inactivation kinetics are 
such that K+ binding to intracellular and extracellular sites of KV1.5 promote two 
components (fast and slow) of P-type channel inactivation (Fedida, Maruoka, & Lin, 
1999). Interestingly, mutation of certain intracellular N-terminus residues in the T1 
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domain switches the KV1.5 inactivation from P- to U-type, drastically altering 
inactivation-voltage relationships (Kurata et al., 2002). Therefore, mutations in KV1.5 
likely have clinical relevance as changes in the KDR of excitatory tissue could possibly 
influence action potential duration/frequency. For instance, some forms of atrial 
fibrillation are proposed to derive from atrial KV1.5 loss-of-function mutations (Olson et 
al., 2006). KV1.5 has also been shown to be expressed in vascular smooth muscle, in 
some studies at high levels relative to other KV1 members, and so too, may present an 
issue with decreased expression in pathologies such as vasospasm (Albarwani et al., 
2003; Cheong, Dedman, & Beech, 2001; Plane et al., 2005; Platoshyn et al., 2006; 
Platoshyn et al., 2001; Pozeg et al., 2003). 
 Cole and colleagues conducted a series of studies that suggest KV1.5 and other KV 
channel members form functional heterotetramers and thus provide great diversity to 
vascular smooth muscle electrophysiology. This finding complicates attempts to 
delineate the importance of KV1.5 in resting arterial tone, however, pharmacological 
evidence from these experiments suggests KV1.5 may be present in all or most 
complexes (Plane et al., 2005). A comparison of native rabbit portal vein myocyte KDR to 
cloned KV1.5 properties revealed many electrophysiological similarities except for some 
components of inactivation (Clement-Chomienne et al., 1999). Subsequently, they later 
identified a complex of KV1.2 and KV1.5 as a putative heteromultimeric channel in rabbit 
portal vein that may attest for the differences in inactivation seen in the previous study 
comparing native cells to a cloned KV1.5 homotetramer (Kerr et al., 2001).  
 In vascular smooth muscle, the normal P-type, slow inactivation phenotype of KV1.5 
would seemingly act as a brake to myogenic constriction with increased intraluminal 
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pressure (myogenic response), counteracting depolarizing fluxes to control arterial tone. 
This has been demonstrated by transfection of murine cerebral arteries with dominant-
negative KV1.5, which had suppressed negative feedback to the myogenic response 
and thusly enhanced arterial constriction with increasing pressure. However, this study 
did not conduct an experiment with 4-AP on resting arterial tone to identify whether KDR, 
and potentially resting membrane potential and tone, were mediated by KV1.5 (Chen, 
Luykenaar, Walsh, Walsh, & Cole, 2006). KV1.5 has been examined in the pulmonary 
circulation due to its role as an oxygen sensor in acute hypoxia, which inhibits the 
channel and depolarizes membrane potential (Platoshyn et al., 2006; Yuan, 1995). In 
resistance pulmonary arteries, KV1.5 current inhibition by antibody binding contributed 
more than KV2.1 to membrane depolarization in rats (Archer et al., 2004). However, few 
investigations have discerned a specific role for KV1.5 in resting arterial tone in other 
vascular beds and at least one account accredits KV2.1, with no role for KV1.5 despite 
its expression, in rat pulmonary artery (Archer et al., 1998). Furthermore, Chong et al. 
show a complete absence of KV1.5 in murine cerebral smooth muscle cells, which 
contradicts other reports (Albarwani et al., 2003; Cheong, Dedman, & Beech, 2001; 
Cheong, Dedman, Xu, et al., 2001).  
 While convincing evidence exists that members of the KV channel superfamily 
control resting membrane potential and therefore regulate arterial tone, a role for KV1.5 
has not been clear in many vascular beds. With the synthesis of DPO-1, however, a 
possible direct pharmacological tool to deduce the role of KV1.5 in this setting is now 
available. DPO-1 comparably varied kinetics of cloned human KV1.5 channels and ultra-
rapidly activating delayed rectifier K+ currents (IKur) of human atrial myocytes expected 
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to be conducted by KV1.5 (Lagrutta, Wang, Fermini, & Salata, 2006). DPO-1 also 
prevented atrial arrhythmias in vivo with no effect in ventricles of dogs, rats, and 
nonhuman primates further supporting the specificity of DPO-1 for KV1.5 versus non-IKur 
channels (Regan, Wallace, Cresswell, Atkins, & Lynch, 2006; Stump, Wallace, Regan, 
& Lynch, 2005). Based on these reports and our own findings, we believe that DPO-1 is 
a sufficient pharmacological tool to pursue the role of KV1.5 in resting arterial tone of a 
variety of vascular beds. In the final section of this introduction to K+ channels and 
arterial tone, we briefly summarize the significance of the current body of work.  
 
Significance of work 
 
 In the subsequent chapters of this document we 1) describe the specificity for DPO-
1 for KV1.5 in a KCNA5 knockout mouse model (Chapter 2), 2) determine a role for 
DPO-1 sensitive KDR channels in tone and reactivity of microvessels (Chapter 2), and 3) 
investigate the effects of DPO-1 on native porcine coronary smooth muscle cell KDR 
channel kinetics (Chapter 3). The goal of this portion of the doctoral dissertation was 
two-fold: First, we examined DPO-1 as a tool for investigating KDR channels in vascular 
smooth muscle, including pressurized vessel and electrophysiological experiments. 
Second, we support a role for KV1.5 in both conduit and resistance type vessels of 
different vascular beds in resting arterial tone.  
 This body of work supports a role for KV channel dependent control of arterial tone 
and membrane potential and suggests that KV1.5 specifically is an important mediator. 
Further investigation of KV member specific drugs and discovery of KV channels that 
regulate resting arterial tone may provide essential therapeutic targets to combat such 
pathologies as hypertension and peripheral vascular disease, especially in small 
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arteries and arterioles. We believe that KV1.5, alone or in complex with other KV 
members, could be one such target.  
 
Introduction to BK and BPA 
 
Estrogen regulation of BK 
 
  Large conductance voltage- and Ca2+-activated K+ (BK) channels are composed of 
four α pore subunits each containing seven transmembrane segments. Auxiliary β 
subunits can alter BK channel properties and in vascular smooth muscle, β1 increases 
the sensitivity to Ca2+ and voltage (Sweet & Cox, 2009). β subunits can also affect or 
mediate the actions of pharmacological agents. For instance, iberiotoxin is a potent 
inhibitor of BK channels but cannot block neuronal BK containing β4 subunits (Meera, 
Wallner, & Toro, 2000). Furthermore, estrogens and xenostrogens (e.g. tamoxifen) 
activate BK channels by binding β1 subunits (Dick, Hunter, & Sanders, 2002; Dick, 
Rossow, Smirnov, Horowitz, & Sanders, 2001; Dick & Sanders, 2001; Valverde et al., 
1999). These findings suggest important physiological roles for BK channels in 
endocrine signaling and emphasize the importance of tissue specific β subunit 
expression.  
  BK channels are dynamically regulated by endogenous endocrine mediators, 
ultimately influencing the expression, splicing, and function of BK. The effect of sex 
hormones and the role BK plays in testicular cells and uterine myometrium have been 
documented. Findings suggest that BK activation reduces androgen production and 
regulates myometrium excitability during gestation (Benkusky, Korovkina, Brainard, & 
England, 2002; Matzkin et al., 2013). In the uterine vasculature estrogen activation of 
BK channels induces vasodilation (Hu et al., 2011; Rosenfeld, Cornfield, & Roy, 2001).  
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It is conceivable that circulating estrogens could reach BK channels located in other 
tissue including brain and non-reproductive vascular beds. One such study investigating 
the estrogenic effects on BK expression revealed tissue specific changes in the 
expression of α and β subunits. Specifically, BK subunit expression was increased in 
aorta while brain BK subunits were unaffected by estrogen (Jamali, Naylor, Kelly, & 
Ronnekleiv, 2003). This is contradicted by data showing that cells transfected with BK α 
and β1 exposed to 17β-estradiol expressed less BK channels than non-exposed cells 
(Korovkina, Brainard, Ismail, Schmidt, & England, 2004). Nonetheless, the putative 
long-term genomic effect of estrogens increasing vascular smooth muscle BK channel 
expression coupled to the acute activation of BK channels inducing vasodilation are 
proposed components of cardioprotective events in women (Jamali et al., 2003). 
However, exposure to endocrine disruptors that contain similar molecular composition 
to estrogens could promote synergistic estrogenic effects or competitive inhibition of 
intracellular signaling targets, perhaps negatively affecting BK channel expression and 
function. 
 
BPA activates BK  
 
 Bisphenol A (BPA) is a byproduct during formation of polycarbonate plastics and 
epoxy resins. Therefore, human exposure to BPA is largely through the diet as many 
plastics and canned goods contain these compounds. The resins that line canned 
goods, for instance, protect consumer goods from contact with metal yet may leach 
BPA instead (Howe & Borodinsky, 1998). This was brought to public attention because 
investigation of BPA exposure in rats suggests maladaptive effects (Farabollini, Porrini, 
& Dessi-Fulgherit, 1999; Khurana, Ranmal, & Ben-Jonathan, 2000; Steinmetz et al., 
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1998). More importantly, the Center for Disease Control estimates over 90% of the 
population contains BPA in the urine (Lakind & Naiman, 2008).  
 Our group recently showed that BPA activates BK channels with and without the β1 
subunit present (S. Asano, Tune, & Dick, 2010). However, the presence of the β1 
subunit increased the potency of BPA by one order of magnitude. BPA also increased 
conductance of BK channels in coronary smooth muscle and we suggest that increased 
BK activity may underlie potential toxicological effects of BPA. However, how the 
membrane permeant-BPA activates BK channels directly is unknown, and we therefore 
set to determine from which side of the cell membrane BPA activates BK channels in 
Chapter 4.  
 
Significance of work 
 
 Xenoestrogens such as BPA are known endocrine disruptors, however, their non-
genomic effects are often not given attention. In Chapter 4, we show published data 
regarding the effect of BPA-monosulfate (BPA-MS) on cloned human BK channels. This 
documents our attempts at determining from which side of the cell membrane BPA 
activates BK channels as the monosulfate moiety renders BPA membrane 
impermeable. The significance of these data resides mostly in pharmacodynamics of 
BPA on BK channels but might also provide toxicological insight to circulating BPA upon 
exposure. Furthermore, we add to a growing body of literature that suggests that BPA 
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Figure 1.1 Cartoon depicting the ionic basis of the membrane potential in arterial 
smooth muscle. The Na+/K+ ATPase moves 2 K+ into the cell and 3 Na+ out of the cell 
against concentration gradients. The result is a separation of ions across the 
sarcolemma. An unknown population of open channels allows K+ efflux and drives 
membrane potential toward EK. However, EK is not reached, as its polarizing influence is 
tempered by depolarizing conductances (Na+, Ca2+, and Cl-); the resulting Em is 
approximately -50 mV. At this potential, L-type Ca2+ channels are just in their active 
voltage range, thus providing the rationale that arterial smooth muscle K+ channels 
control arterial tone. Specifically, if more K+ channels open, Em is hyperpolarized, L-type 
channels close, and tone is reduced (vasodilation). Conversely, if K+ channels are 







Figure 1.2 Cartoon depicting K+ channel expression in arterial smooth muscle. K+ 
channels expressed in arterial smooth muscle include Ca2+-activated (SK, BK, and IK) 
channels, KATP channels comprised of the Kir6.1 pore and SUR2B regulatory subunit, 
and members of the KV superfamily (KV1, KV2, KV3, KV4, KV7, and the silent KVs: KV5 
and 9). It should be noted that only specific members from each subfamily are 
expressed and some members are exclusive to certain vascular beds. It is our 
supposition that a member of the KV1 subfamily is important for controlling Em and 










Figure 1.3 Arterial smooth muscle KV family tree. The phylogeny of KV channels 
expressed in arterial smooth muscle is shown. The figure is adapted from Guttman et al. 
where CLUSTALW alignment of sequences was followed by Phylogenetic Analysis 
Using Parsimony to construct the family tree (Gutman et al., 2005). Members of the 
silent KVS subfamilies are not depicted. It is our supposition that KV1.5 contributes to Em 









Figure 1.4 Example traces of delayed rectifier (KDR) current in smooth muscle cells 
isolated from the porcine right coronary artery. A) A 300 ms ‘short’ pulse shows the fast 
activation of KDR channels upon a +20 mV stimulus. Stepping back to -40 mV 
deactivates KDR channels and produces tail currents. B) A 5 s ‘long’ pulse clearly shows 
that, in the continued presence of the +20 mV stimulus, KDR channels inactivate over 
time. In Chapter 3, we use these biophysical properties and pharmacology to 











Figure 1.5 KV1.5 topology and assembly. A) KV1.5 has six transmembrane segments, 
where S1-S4 comprises the voltage-sensing domain. The S4 segment contains 
positively charged arginine and lysine residues sensitive to membrane depolarization 
and responsible for gating charges. The N-terminal T1 domains are regulatory sites as 
well as mediators of inactivation. B) Assembly of four separate KV1.5 subunits into a 
single functional K+-selective ion channel is shown. T1 domains from each individual 
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Objective: Many types of vascular smooth muscle cells exhibit prominent delayed 
rectifier K+ (KDR) currents. These KDR currents may be mediated, at least in part, by 
KV1.5 channels, which are sensitive to inhibition by diphenyl phosphine oxide-1 (DPO-
1). We tested the hypothesis that DPO-1-sensitive KDR channels regulate the tone and 
reactivity of resistance-sized vessels from rat brain (middle cerebral artery) and skeletal 
muscle (gracilis artery). Methods: Middle cerebral and gracilis arterioles were isolated 
and subjected to three kinds of experimental analysis: a) Western blot; b) patch clamp 
electrophysiology; and c) pressure myography. Results: Western blot experiments 
demonstrated KV1.5 immunoreactivity in arterioles. Whole-cell patch clamp experiments 
revealed arteriolar smooth muscle cells to possess a KDR current that was blocked by 
DPO-1. Arterioles constricted in response to increasing concentrations of DPO-1. DPO-
1 enhanced constrictions to phenylephrine and serotonin in gracilis and middle cerebral 
arterioles, respectively. The relationship between diameter and internal pressure (i.e., 
myogenic response) was shifted down in parallel fashion by DPO-1. Dilations in 
response to acetylcholine were reduced by DPO-1. Conclusion: We suggest that 
KV1.5, a DPO-1-sensitive KDR channel, plays a major role in determining microvascular 
tone and the arteriolar response to vasoconstrictors and vasodilators. 
 
Key words: diphenyl phosphine oxide-1; delayed rectifier potassium current; KCNA5; 




 Resistance vessels regulate tissue perfusion by integrating a variety of stimuli. 
Microvascular adjustments include: a) myogenic responses; b) metabolic vasodilation; 
c) vasoconstriction in response to neurohumoral factors; and d) vasodilation due to flow 
and paracrine agents. While some of the mechanisms involve endothelial cells and 
sympathetic nerves, it is the contractile state of smooth muscle that is the final element 
in any of the pathways. When it comes to smooth muscle, however, a knowledge gap 
exists regarding the end effectors controlling membrane potential and, thus, the 
intracellular Ca2+ concentration and vascular tone. K+ channels are known to regulate 
this process of electromechanical coupling, but the type of K+ channel(s) involved is less 
clear. It is our supposition that voltage-dependent K+ (KV) channels, especially the 
delayed rectifier (KDR) type of KV channels, are critically important for regulating 
arteriolar vascular reactivity.  
Vascular smooth muscle cells express a variety of K+ channels, including KDR 
channels (Dick & Tune, 2010). The K+ channels of microvascular smooth muscle have 
been reviewed previously (Jackson, 1998, 2005). KDR channels produce a prominent 
current in the physiological voltage range (Gollasch, Ried, Bychkov, Luft, & Haller, 
1996; Volk, Matsuda, & Shibata, 1991). Evidence suggests that these KDR channels are 
important for the membrane potential and reactivity of smooth muscle (Knot & Nelson, 
1995) in regulating tissue blood flow (Dick et al., 2008). There are 100-plus K+ channel 
gene loci in the human genome and more than one-third of them encode KV channels 
(including both pore-
the sheer number of candidates, it has been difficult to determine the molecular entities 
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underlying the KDR channels of smooth muscle. Excellent evidence, however, supports 
a role for the KV1 subfamily (Albarwani et al., 2003; Chen, Luykenaar, Walsh, Walsh, & 
Cole, 2006; Cheong, Dedman, & Beech, 2001; Plane et al., 2005), particularly KV1.5 
(Clement-Chomienne, Ishii, Walsh, & Cole, 1999; Kerr et al., 2001; Thorneloe et al., 
2001). 
 Recently, novel and selective KV1.5 channel inhibitors have become available, 
including diphenyl phosphine oxide-1 (DPO-1) (Lagrutta, Wang, Fermini, & Salata, 
2006; Regan, Wallace, Cresswell, Atkins, & Lynch, 2006; Stump, Wallace, Regan, & 
Lynch, 2005). DPO-1 allows us to test whether KDR channels of arteriolar smooth 
muscle contain KV1.5 as a major component. Further, it lets us test whether DPO-1-
sensitive KDR channels control the tone and reactivity of resistance-sized arterioles from 
brain (middle cerebral artery; MCA) and skeletal muscle (gracilis artery; GA). In the 
present study, we describe the presence of KV1.5 immunoreactivity in rat MCA and GA 
as well as DPO-1-sensitive KDR current in smooth muscle cells isolated from MCA and 
GA. Further, we provide functional data indicating that inhibition of KDR by DPO-1 
increases the sensitivity of contraction to phenylephrine (PE) and serotonin (5-HT) and 
reduces vasodilation to acetylcholine (ACh). These data lead us to suggest that DPO-1-
sensitive KV1.5 channels play a major role in determining microvascular tone and the 




Animal care and use. Animal studies were approved by an institutional Animal 
Care and Use Committee and conformed to recommendations of the National Research 
Council (National Research Council, 2011). Male Sprague Dawley rats (200-250 g) 
were given access to standard chow and water ad libitum. Rats were anesthetized with 
sodium pentobarbital (150 mg/kg, i.p.). A carotid artery was cannulated to record mean 
arterial pressure, as this value was required to calculate the appropriate distending 
pressure for pressure myography experiments. Animals were euthanized and the MCA 
and GA were removed. Arterioles were stored at -80 °C for molecular analysis or used 
the same day for patch clamp electrophysiology and pressure myography. 
In another set of experiments designed to test the specificity of DPO-1, we used 
smooth muscle cells isolated from the aortae of wild type and KV1.5 knockout (KO; 
KCNA5-/-) mice. Tissues taken from these animals were kindly provided by Dr. William 
Chilian (Northeast Ohio Medical University; Rootstown, OH) (Ohanyan, Bratz, Guarini, 
Yin, & Chilian, 2010 (Abstract)). 
Western blots. MCA and GA lysates (20 μg of protein) were loaded onto 4-12% 
polyacrylamide gels, separated by electrophoresis, and transferred to polyvinylidene 
difluoride membranes. A rabbit primary antibody targeting the intracellular C-terminus of 
Kv1.5 (Alomone; 1:200) and an anti-rabbit secondary antibody conjugated to 
horseradish peroxide were used. Membranes were incubated with SuperSignal West 
Dura substrate (Thermo Scientific) and bands were imaged using a G-Box detection 
system (Syngene).  
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 Patch clamp electrophysiology. Mouse aortae and rat MCA and GA were treated 
with a low Ca2+ physiological saline solution (PSS) supplemented with (mg/ml) 2 
collagenase, 1 elastase, 1 soybean trypsin inhibitor and 1 bovine serum albumin at 
37°C for 30 minutes. Low Ca2+ PSS contained (mM) 135 NaCl, 5 KCl, 0.36 CaCl2, 1 
MgCl2, 10 glucose, 10 HEPES, and 5 Tris; pH 7.4. Arterioles were then gently passed 
through the tip of a fire-polished Pasteur pipet to isolate single smooth muscle cells. 
Arteriolar smooth muscle cells were pelleted at 400 g for 5 minutes and resuspended in 
PSS. A drop of this cell suspension was placed on a glass chip, cells were allowed to 
adhere, and then the chip was placed into the recording chamber (volume 
approximately 300 μl) atop an inverted microscope. PSS flowed through the chamber at 
approximately 3 ml/min. The bath solution contained (in mM) 135 Na-isethionate, 5 K-
gluconate, 2 MnCl2, 1 MgCl2, 10 glucose, 10 HEPES, 5 Tris; pH 7.4. Whole-cell patch 
access was obtained using heat polished borosilicate glass pipets with resistances of 2-
5 MΩ. Pipets were filled with a solution containing (in mM) 140 K-gluconate, 1 MgCl2, 3 
Mg-ATP, 1 Na-GTP, 10 BAPTA, 10 HEPES, and 5 Tris, pH 7.1. Ca2+-activated currents 
were limited by the nominally Ca2+-free PSS and the 10 mM BAPTA pipette. Cl- currents 
were minimized by the anion replacement. Penitrem A (1 μM) and glibenclamide (10 
μM) further minimized the contribution of BK and KATP currents, so that KDR could be 
studied in relative isolation. Upon whole-cell access, series resistance and capacitance 
were compensated as fully as possible and a voltage template of -60 mV to +20 mV 
was applied in 10 mV steps. Currents were filtered at 1 kHz and digitized at 5 kHz. 
Pressure myography. Resistance arterioles were cannulated and pressurized to 
80% of mean arterial pressure (83 ± 3 mm Hg) and visualized using a video 
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microscope, as described previously (Butcher, Goodwill, & Frisbee, 2012). 
Measurements of arteriole diameter were made using video calipers before and after 
DPO-1 (Tocris; stock solutions prepared in ethanol). Experiments included determining 
the response of arterioles to increasing concentrations of DPO-1 and the effect of DPO-
1 on: a) myogenic responses (40-140 mmHg in random order 20 mmHg steps); b) 
constrictions to 5-HT in MCA and PE in GA); and 3) dilations to ACh. 
Statistics. Two-way repeated measures analysis of variance (2RM-ANOVA) was 
used to analyze data, including: a) current-voltage (I-V) relationships in arteriolar 
smooth muscle cells before and after addition of DPO-1 and b) arteriolar responses to 
constrictors, pressure, and ACh before and after DPO-1. A value of p < 0.05 was 
considered significantly different and Bonferroni post-hoc analysis followed 2RM-




Expression of KV1.5. Fig. 1 shows KV1.5 protein expression in MCA and GA. 
Probing for KV1.5 protein in MCA and GA lysates detected a single band between 50 
and 70 kDa (Fig. 1). The predicted molecular weight of KV1.5 is approximately 66 kDa. 
 KDR channels are blocked by DPO-1. To determine the specificity of DPO-1 as a 
pharmacological tool to inhibit KV1.5-containing KDR channels, we measured whole-cell 
currents of smooth muscle cells isolated from the aortae of wild type and KV1.5 KO mice 
(Figs. 2A and B). Current was significantly smaller in cells from KV1.5 KO mice (Fig. 
2C), indicating that KV1.5 subunits are important for forming KDR channels in vascular 
smooth muscle. DPO-1 (1-10 μM) significantly inhibited current in smooth muscle cells 
from wild type, but not KV1.5 KO mice (Figs. 2D, 2E, and 2F). These data indicate that 
DPO-1 is a KV1.5-selective inhibitor. 
 We performed whole-cell patch clamp experiments to investigate the effect of DPO-1 
on KDR channel currents in vascular smooth muscle cells isolated from rat MCA and GA. 
Depolarization elicited robust KDR currents in cells from the MCA and GA (Fig. 3A and 
B, control). DPO-1 (10 μM) inhibited KDR current in smooth muscle cells from both the 
MCA and GA (Fig. 3A and B, DPO-1). Fig. 3C and D contain the current-voltage 
relationships for cells isolated from the MCA and GA, respectively. In cells from the 
MCA, 10 μM DPO-1 inhibited current significantly at potentials greater than or equal to -
20 mV (e.g., current block at 0 mV was 74 ± 4%, n = 6). Similarly, in cells from the GA, 
10 μM DPO-1 inhibited current significantly at potentials greater than or equal to -10 mV 
(e.g., current block at 0 mV was 61 ± 7%, n = 4).  
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Inhibition of KDR channels constricts arterioles. We investigated the effect of KDR 
channel inhibition on the diameter of arterioles with active tone. MCA and GA were 
cannulated and pressurized to 80% of mean arterial pressure. The resting diameters of 
MCA and GA were 105 ± 3 and 105 ± 1 μm, respectively (n = 4 each). When increasing 
concentrations of DPO-1 (10 nM, 100 nM, 1 μM, and 10 μM) were added to MCA, 
diameter decreased 4 ± 1, 11 ± 1, 21 ± 2, and 24 ± 2%, respectively (Fig. 4A). Similarly, 
when the same increasing concentrations of DPO-1 were added to GA, diameter 
decreased 5 ± 1, 12 ± 1, 16 ± 3, and 20 ± 3% (Fig. 4B). Constrictions in response to 
DPO-1 were statistically significant with all concentrations of DPO-1 that were tested 
(10 nM and higher). 
DPO-1 increases the sensitivity to vasoconstrictors. 5-HT and PE were used to 
constrict MCA and GA, respectively. We performed concentration-response 
experiments with these constrictors before and after arterioles were treated with 10 μM 
DPO-1. When pressurized to 80% of mean arterial pressure, MCA diameter was 101 ± 
3 μm (n = 8). MCA contracted 1 ± 1, 6 ± 1, 13 ± 1, 21 ± 2, 32 ± 2, and 36 ± 3% in 
response to 0.001, 0.01, 0.1, 1, 10, and 100 μM 5-HT (Fig. 5A). DPO-1 constricted MCA 
to 76 ± 3 μm. In the presence of DPO-1, responses to the same 5-HT concentrations 
were 2 ± 1, 12 ± 2, 19 ± 3, 24 ± 4, 30 ± 3, and 33 ± 4% (Fig. 5A). Compared to control, 
MCA diameter in the presence of DPO-1 was significantly different at baseline and 
every 5-HT concentration. GA diameter under control conditions was 105 ± 2 μm (n = 
8). GA contracted 2 ± 1, 6 ± 1, 13 ± 1, 21 ± 1, 29 ± 2, and 43 ± 1% in response to 0.001, 
0.01, 0.1, 1, 10, and 100 μM PE (Fig. 5B). DPO-1 constricted MCA to 79 ± 2 μm. In the 
presence of DPO-1, responses to the same PE concentrations were 1 ± 1, 6 ± 2, 18 ± 3, 
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29 ± 3, 34 ± 3, and 40 ± 3% (Fig. 5B). GA diameter in the presence of DPO-1 was 
significantly different at baseline and every PE concentration when compared to the 
control condition. When normalized to the maximum response, the effect of DPO-1 to 
enhance the sensitivity to vasoconstrictors can be appreciated (Fig. 5C and 5D). 
DPO-1 and myogenic tone. We investigated the effect of KDR channel inhibition 
on the myogenic responses of MCA and GA. With 80 mmHg of pressure, the diameters 
of MCA and GA were 107 ± 3 and 106 ± 1 μm, respectively (n = 4 each). When 
pressure was reduced to 60 and then 40 mmHg, MCA dilated 5 ± 2 and then 7 ± 3% 
(Fig. 6A). When pressure was increased to 100, 120, and then 140 mmHg, MCA 
constricted 5 ± 1, 11 ± 1, and 15 ± 2% (Fig. 6A). After treating MCA with 1 μM DPO-1, 
the arterioles constricted to 85 ± 1 μm. Further, in the presence of DPO-1, the dilations 
to reduced pressure were 3 ± 1 and then 4 ± 2% (Fig. 6A) and the constrictions to 
increased pressure were 6 ± 1, 11 ± 1, and 17 ± 2% (Fig. 6A). Thus, DPO-1 produces a 
parallel shift in the relationship between internal pressure and diameter, but myogenic 
activity is still present. In GA, when pressure was reduced from 80 to 60 and then 40 
mmHg, arterioles dilated 4 ± 1 and then 6 ± 1% (Fig. 6B). When pressure was 
increased to 100, 120, and then 140 mmHg, MCA constricted 5 ± 1, 10 ± 1, and 14 ± 
2% (Fig. 6B). After treating arterioles with 1 μM DPO-1, GA constricted to 93 ± 4 μm. 
Further, in the presence of DPO-1, the dilations to reduced pressure were 1 ± 2 and 
then 4 ± 2% (Fig. 6B) and the constrictions to increased pressure were 7 ± 1, 12 ± 3, 
and 17 ± 4% (Fig. 6B). Similar to MCA, DPO-1 shifts the pressure-diameter relationship 
in a parallel fashion in GA, but myogenic activity is still exhibited. 
 55 
 DPO-1 inhibits endothelium-dependent vasodilation. ACh was used to induce 
endothelium-dependent vasodilation in MCA and GA. We performed concentration-
response experiments before and after DPO-1 (10 μM) treatment in pressurized 
arterioles. In this set of experiments, the baseline diameter of MCA was 101 ± 2 μm (n = 
8). MCA relaxed 3 ± 1, 6 ± 1, 12 ± 1, 17 ± 2, 20 ± 2, and 25 ± 1% in response to 0.001, 
0.01, 0.1, 1, 10, and 100 μM ACh. DPO-1 significantly reduced MCA baseline diameter 
to 81 ± 2 μm and impaired vasodilation to ACh, When KV1.5 was inhibited with DPO-1, 
relaxations to the same ACh concentrations were -1 ± 1, 1 ± 2, 6 ± 2, 9 ± 3, 8 ± 4, and 8 
± 5% (Fig 7A). The baseline diameter for GA in this set of experiments was 103 ± 3 μm 
(n = 8). GA relaxed 2 ± 1, 5 ± 3, 10 ± 1, 15 ± 2, 20 ± 2, and 26 ± 2% in response to 
0.001, 0.01, 0.1, 1, 10, and 100 μM ACh. DPO-1 significantly reduced baseline diameter 
to 78 ± 2 μm and impaired vasodilation to ACh, significantly reducing responses to -1 ± 
1, 0 ± 3, 2 ± 3, 7 ± 2, 7 ± 2, and 9 ± 2% (Fig. 7B).  
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Discussion 
Our data support the hypothesis that DPO-1-sensitive KDR channels regulate the 
tone and reactivity of resistance-sized vessels from rat brain and skeletal muscle; 
therefore, suggesting KV1.5 subunits are included in microvascular KDR channels. This 
conclusion is based on four lines of evidence. First, we demonstrated that rat MCA and 
GA expressed KV1.5 protein. Second, we confirmed that DPO-1 is a KV1.5-selective 
inhibitor (established by inhibitory effects in smooth muscle cells from wild type but not 
KV1.5 KO mice). Third, we documented DPO-1-sensitive KDR currents in smooth muscle 
cells isolated from rat MCA and GA. Fourth, pressure myography experiments revealed 
powerful effects of DPO-1-sensitive KDR channels to control diameter, impact myogenic 
reactivity, and shape responses to vasoconstrictors and vasodilators. We suggest that 
KV1.5, a DPO-1-sensitive KDR channel, plays a major role in determining microvascular 
tone and the arteriolar response to pressure, vasoconstrictors, and vasodilators. This 
novel finding supports and extends previous studies indicating roles for KDR channels in 
arteriolar smooth muscle and microvascular tone by examining effects of 4-
aminopyridine and/or correolide (Table 1).  
The information in Table 1 helped firmly establish that KDR channels regulate 
arteriolar vascular reactivity, but the molecular identity of these channels has remained 
unclear. Previous studies aimed at determining the molecular correlates of KDR 
channels are available in smooth muscle from a variety of vascular beds and ranging 
from conduit arteries to the microcirculation. A general logical framework has evolved 
for differentiating two major types of KDR channels and it centers on sensitivity to 
tetraethylammonium (TEA) (Cox, 2005). TEA-sensitive KDR channels most likely contain 
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KV2 or KV3 family members, whereas TEA-insensitive KDR channels are thought to 
contain KV1 subunits (including KV1.5 and perhaps also including KVβ subunits). Both 
varieties of KDR channels may be present in a single smooth muscle type, but our study 
addressed only KV1-containing KDR channels.  
In the present study, we observed the expression of KV1.5 protein in resistance 
arterioles of rat brain and skeletal muscle using Western blot techniques (Fig. 1). This 
agrees with findings of Kang et al., who demonstrated KV1.5 expression by Western blot 
in arterioles from rat gastrocnemius and soleus muscles (Kang et al., 2009). Our data 
also correspond to immunhistochemical data from three other groups examining KV1.5 
expression in arterioles or their cells. Cheong et al. observed KV1.5 immunostaining in 
smooth muscle cells of rabbit cerebral arterioles (Cheong, Dedman, & Beech, 2001). 
They observed immunoreactivity for KV1.6 in smooth muscle as well, but KV1.2 had an 
endothelial-only staining pattern (Cheong, Dedman, & Beech, 2001). Albarwani et al. 
demonstrated KV1.2 and KV1.5 immunoreactivity in single smooth muscle cells isolated 
from rat cerebral arterioles (Albarwani et al., 2003). McGahon et al. reported KV1.5, but 
not KV1.4, immunoreactivity in smooth muscle cells from rat retinal arterioles (McGahon 
et al., 2007). They also observed the expression of KV
KV1.5 currents from the KDR type to an A-type waveform (McGahon et al., 2007). Our 
data and the studies described above differ dramatically from another effort of Cheong 
et al. (Cheong, Dedman, Xu, & Beech, 2001), and suggest there may be species- or 
vascular bed-specific differences in KDR composition. Specifically, in mouse cerebral 
arterioles, Cheong et al. observed no immunostaining for KV1.5; rather they detected 
KV1.2 in endothelium and KV1.3, KV1.4, and KV1.6 in smooth muscle and endothelium 
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(Cheong, Dedman, Xu, et al., 2001). The lack of KV1.5 in mouse cerebral arterioles is at 
odds with our data showing differences in KDR current in aortic smooth muscle between 
wild type and KV1.5. KO mice (Fig. 2). However, our data complement those of Fountain 
et al. who demonstrated smooth muscle-specific expression of KV1.5 mRNA in mouse 
aorta, as well as correolide-sensitive KDR current in murine aortic myocytes (Fountain et 
al., 2004). 
A major consideration for our study is whether DPO-1 is a KV1.5-specific 
pharmacological tool. The literature would suggest that it is indeed a selective inhibitor 
(Lagrutta et al., 2006; Regan et al., 2006; Stump et al., 2005), but we designed a set of 
experiments to address this point ourselves. Specifically, we isolated smooth muscle 
cells from the aortae of wild type and KV1.5 KO mice and used patch clamp techniques 
to assess drug specificity. DPO-1 inhibited KDR current in myocytes from wild type mice 
(Fig. 2), which suggests that KV1.5 subunits are indeed expressed in murine aortic 
smooth muscle. However, this conclusion would be erroneous if DPO-1 were also found 
to inhibit KDR current in aortic myocytes from KV1.5 KO mice (i.e., it blocked KV channel 
types other than KV1.5). We observed no significant inhibition of KDR current by DPO-1 
in aortic myocytes of KV1.5 KO, mice (Fig. 2). Thus, we suggest that DPO-1 is KV1.5-
selective and our conclusion agrees with findings of Lagrutta et al., who demonstrated 
DPO-1 selectivity for KV1.5 (and native IKur) over Ito, IK1, IKr, IKs, and KV3.1 (Lagrutta et 
al., 2006). We observed DPO-1-sensitive KDR currents in smooth muscle cells isolated 
from rat MCA and GA (Fig. 3). We interpret that to mean that these microvascular KDR 
channels contained KV1.5 subunits, which corroborates the expression of KV1.5 protein 
in MCA and GA (Fig. 1). DPO-1 right-shifted the reversal of the whole-cell current-
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voltage relationship (indicating a theoretical depolarization; Fig. 3), which suggests that 
KV1.5-containing KDR channels may help set resting membrane potential and thus 
control resting vascular tone. 
Accordingly, we observed that inhibition of KV1.5-containing KDR channels with 
DPO-1 significantly constricted MCA and GA, i.e., altered the vascular tone at a typical, 
physiological distending pressure (Fig. 4). Many of the studies in Table 1 support this 
idea that KDR channels control resting microvascular tone, but used less selective 
inhibitors such as 4-AP and correolide (which were the best available tools at the time). 
None of the studies in Table 1 show that KDR channels control microvascular reactivity 
to vasoconstrictors, but this is an idea worth testing, as K+ channels are known to 
“dampen’ or “buffer” excitation in the microvasculature (Hald et al., 2012). Thus, we 
tested the reactivity to vasoconstrictors (5-HT and PE for MCA and GA, respectively) 
before and after inhibition of KV1.5-containing KDR channels with DPO-1 (Fig. 5). DPO-1 
significantly left-shifted the concentration-response curves in both MCA (5-HT) and GA 
(PE). We interpret this to mean that KV1.5-containing KDR channels provide a critical, 
physiological negative feedback against vasoconstriction. While not well documented, 
this is not entirely surprising, as part of the mechanism of 5-HT vasoconstriction may be 
inhibition of KV1.5 channels (Cogolludo et al., 2006). There are no comparable data 
showing PE-induced inhibition of KV1.5 in the vasculature, but PE inhibits atrial IKur 
(thought to be KV1.5) (Van Wagoner, Kirian, & Lamorgese, 1996). Luykenaar and 
colleagues have previously proposed the idea that vasoconstrictors act, in part, by 
inhibiting KDR currents in cerebral microvascular smooth muscle (Luykenaar, Brett, Wu, 
Wiehler, & Welsh, 2004; Luykenaar, El-Rahman, Walsh, & Welsh, 2009). We suggest 
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that KV1.5-containing KDR channels are important in determining microvascular 
responses to neural and humoral vasoconstrictors. 
Another important adjustment that resistance vessels make is diameter changes 
in response to distending pressure (i.e., myogenic responses). Several of the studies in 
Table 1 demonstrate that pharmacological inhibition of microvascular KDR channels 
augments myogenic reactivity. However, using molecular tools (dominant-negative 
KV1.5 and KV1.5 overexpression techniques), it has been more convincingly shown that 
KV1.5 channels can affect the myogenic reactivity of rat cerebral arterioles (Chen et al., 
2006). Specifically, Chen et al. have shown that: a) suppression of KV1-containing KDR 
channels with correolide enhances cerebral myogenic responses (similar to other 
studies in Table 1); b) dominant-negative KV1.5 enhances cerebral myogenic 
responses; and c) overexpression of wild type KV1.5 suppresses cerebral myogenic 
responses (Chen et al., 2006). Those novel findings led us to investigate the effects of 
DPO-1 on the myogenic response of MCA and GA (Fig. 6). Inhibition of KV1.5-
containing KDR channels with DPO-1 decreased the dilation of MCA and GA to lowered 
pressures and increased the constrictions to higher pressures. Overall, a parallel 
downward shift in the diameter-pressure relationship was observed. Together these 
findings indicate that KV1.5-containing KDR channels act as negative feedback elements 
to maintain appropriate physiological tone, promoting vasodilation under low pressure 
and regulating constriction under high pressure.  
 To test the role of KV1.5-containing KDR channels as end effectors of vasodilation in 
MCA and GA, we conducted concentration-response experiments with ACh in the 
presence of DPO-1 (Fig. 7). With endothelial stimulation, mediators are released that 
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open vascular smooth muscle K+ channels, hyperpolarize membrane potential, and 
dilate the vessel (Waldron & Cole, 1999). DPO-1 impaired the response to ACh in MCA 
and GA, suggesting that KV1.5-containing KDR channels in microvascular smooth 
muscle are signaling targets in endothelium-dependent vasodilation. An alternative 
interpretation might be that KV1.5 is also expressed in endothelial cells; therefore, DPO-
1 might inhibit endothelium-dependent vasodilation by depolarizing the endothelium and 
decreasing the driving force for Ca2+ entry that is required for production of some 
relaxing/hyperpolarizing factors. At present, it is unclear what is the individual 
contribution of nitric oxide, prostaglandins, or other endothelial-derived hyperpolarizing 
factors, but there is evidence that protein kinase A and G pathways signal to 
microvascular KDR channels (Luykenaar & Welsh, 2007). 
 We conclude that DPO-1 inhibits KDR channels in microvascular smooth muscle, 
indicating that these channels contain KV1.5 subunits. Our data indicate that these 
KV1.5-containing KDR channels help set resting arteriolar tone and play an important role 
in microvascular reactivity to pressure and vasoactive agents. Further investigation of 
KV1.5-containing KDR channels and how they function to regulate arteriolar tone and 
reactivity could help us understand how systemic blood pressure is maintained as well 
shed light on how tissue blood flow is controlled. Additionally, further study of KV1.5-
containing KDR channels may reveal therapeutic targets for treating conditions such as 




The present study contributes to an existing body of literature concerning the regulation 
of arteriolar function by K+ channels, which suggests that KV1 family members are major 
components of KDR channels in microvascular smooth muscle. We add to this 
knowledge by demonstrating that a specific member of the KV1 family, KV1.5, is a 
prominent subunit in microvascular smooth muscle, and moreover, that these KV1.5-
containing channels regulate resistance vessel tone and reactivity. Information about 
specific KV channel members in resistance vessels could identify new therapeutic 
targets in treating cardiovascular diseases. Possibilities include the development of 
subunit-specific drugs that could be used to modulate inappropriate microvascular tone 
(e.g., KV-specific openers to ameliorate hypertension or KV-specific antagonists to treat 
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Figure 2.1 KV1.5 protein in resistance arteries. A representative Western blot is shown. 
Whole vessel lysate (15-20 μg protein) was loaded. The numbers on the left indicate 
molecular weights of markers in kDa. A band of KV1.5 immunoreactivity was detected 









Figure 2.2 DPO-1-sensitive currents are absent in the smooth muscle cells from KV1.5 
knockout mice. Panels A and B contain current traces from aortic myocytes isolated 
from wild type and KV1.5 knockout mice. The voltage template is shown below A. Panel 
C contains group data (n = 4 mice in each group) illustrating reduce current density in 
cells from KV1.5 knockout mice. Panels D and E contain currents elicited at +20 mV and 









Figure 2.3 DPO-1-sensitive KDR current in arteriolar smooth muscle. Current traces from 
representative smooth muscle cells are shown in panels A (MCA) and B (GA) before 
and after the addition of 10 μM DPO-1. The membrane potential of cells was stepped in 
10 mV increments from -60 mV to +20 mV (holding potential was -80 mV). DPO-1 (10 
μM) inhibited KDR currents in smooth muscle cells from both types of arterioles. Panels 
C and D contain group I-V data for cells from the MCA (n = 6) and GA (n = 4). Asterisks 








Figure 2.4 Concentration-dependent effect of DPO-1 on arteriolar diameter. MCA (panel 
A; n = 4) and GA (panel B; n = 4) were pressurized to 80% of mean arterial pressure for 
video measurements of diameter. Arterioles were treated with increasing concentrations 
of DPO-1, which elicited constriction. Asterisks indicate concentrations at which DPO-1 







Figure 2.5 DPO-1 augments contractions to serotonin and phenylephrine. Inhibition of 
KDR by DPO-1 (10 μM) augmented constriction to 5-HT in MCA (Panel A; n = 8) and to 
PE in GA (Panel B; n = 8). In the presence of 10 μM DPO-1 both 5-HT and PE 
significantly decreased diameters from the respective control curve. When normalized 
to maximum effects, the 5-HT and PE concentration-response curves were significantly 








Figure 2.6 DPO-1 shifts the myogenic response. Changes in intraluminal pressure in the 
presence of DPO-1 cause a shift toward smaller diameters in MCA (Panel A) and GA 





Figure 2.7 Relaxations to acetylcholine are impaired by DPO-1. N = 8 arterioles for both 
panels. 10 μM DPO-1 significantly reduced vasodilation to each concentration of ACh in 
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Delayed rectifier K+ (KDR) currents help control the contraction of vascular smooth 
muscle. We recently demonstrated that inhibition of KDR channels with diphenyl 
phosphine oxide-1 (DPO-1) dramatically alters arteriolar reactivity. Importantly, 
however, it remains unknown how DPO-1 blocks these channels. Our goal was to 
identify mechanisms involved in DPO-1-induced inhibition of smooth muscle KDR 
channels. Whole-cell patch clamp experiments were performed on myocytes isolated 
from the porcine coronary artery. DPO-1 blocked KDR with an IC50 of 212 ± 28 nM. In the 
presence of DPO-1, the voltage window for channel function diminished, as the voltage 
of ½ inactivation was hyperpolarized (-11 ± 1 vs. -16 ± -1 mV) and the extent of 
inactivation more complete (74 ± 3 vs. 99 ± 1%). During a depolarizing pulse, KDR 
channels inactivated by a process fit with fast and slow time constants (0.52 ± 0.07 and 
5.8 ± 1.1 s, respectively); DPO-1 accelerated both components of inactivation (0.14 ± 
0.01 and 0.6 ± 0.2 s). DPO-1 also prolonged recovery from inactivation (320 ± 10 vs. 
910 ± 107 ms). These findings indicate that DPO-1 blocks KDR channels in coronary 
vascular smooth muscle by: 1) reducing the voltage window for channel function (i.e., 
decreasing area under the voltage-dependent activation and inactivation curves); 2) 
accelerating the transition from the open to closed state in the presence of stimulus; and 
3) delaying recovery from voltage-dependent inactivation. These biophysical 
mechanisms may help explain why DPO-1 so severely impacts smooth muscle 
reactivity. 
Keywords: voltage-dependent K+ channels, KV1.5, KCNA5, and vascular smooth 




Voltage-dependent K+ (KV) channels are studied in a variety of cells because 
they are so important in controlling excitability. This is precisely why so much research 
focuses on pharmaceutical agents that open and close KV channels, as they have 
applications for treating conditions including epilepsy (e.g., retigabine), pain (e.g., 
flupirtine), and atrial fibrillation (e.g., dofetilide). With regard to atrial fibrillation, it was 
the discovery of rare gain-of-function mutations in several K+ channels (e.g. KCNQ1) 
that provided the therapeutic rationale for treating the condition with K+ blockers (Y. H. 
Chen et al., 2003). One particularly attractive drug target in treating atrial arrhythmias is 
KV1.5. This is because: a) KV1.5 mediates the atrial ultra-rapid delayed rectifier K
+ 
current (IKur); b) blocking this IKur prolongs the atrial action potential; and c) IKur is not 
found in the human ventricle (obviating concern about effects on inotropy, etc.) (Brendel 
& Peukert, 2003). Thus, the search for KV1.5-specific blockers commenced and several 
candidates emerged, including diphenyl phosphine oxide-1 (DPO-1) (Lagrutta, Wang, 
Fermini, & Salata, 2006; Regan, Wallace, Cresswell, Atkins, & Lynch, 2006; Stump, 
Wallace, Regan, & Lynch, 2005). Unfortunately, low oral bioavailability ended the 
progression of DPO-1 towards clinical trials; however, we are left with a very KV1.5-
selective pharmacological tool. 
While IKur is not expressed in the human ventricle, the distribution of KV1.5 is 
certainly not limited to atria. In fact, the coronary vessels are strongly positive for KV1.5 
immunoreactivity (Mays, Foose, Philipson, & Tamkun, 1995). Moreover, previous 
studies have suggested that KV1.5 is a component of delayed rectifier K
+ (KDR) channels 
in a variety of vascular smooth muscle cell types (T. T. Chen, Luykenaar, Walsh, Walsh, 
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& Cole, 2006; Kerr et al., 2001; Plane et al., 2005; Thorneloe et al., 2001). We recently 
demonstrated that inhibition of smooth muscle KDR channels with DPO-1 dramatically 
alters the reactivity of arterioles from brain and skeletal muscle (Fancher et al., in 
revision, see Chapter 2). Importantly, however, it remains unknown how DPO-1 blocks 
these channels; therefore, our goal in the present study was to identify mechanisms 
involved in DPO-1-induced inhibition of smooth muscle KDR channels.    
DPO-1 has been suggested as a specific inhibitor of human KV1.5 with an IC50 of 
approximately 160 nM at a pulse frequency of 0.1 Hz (Lagrutta et al., 2006). Further, at 
least six hydrophobic residues found in the S6 domain have been shown to play a role 
in DPO-1-induced inhibition of KV1.5 (Du et al., 2010). DPO-1 inhibits cloned KV1.5 in a 
frequency- and voltage-dependent manner, indicative of open state block (Du et al., 
2010; Lagrutta et al., 2006). DPO-1 increases atrial action potential duration and 
terminates atrial fibrillation by inhibiting KV1.5-mediated IKur. Thus, while the effects of 
DPO-1 on atrial and cloned KV1.5 channels are well documented, the mechanisms of 
DPO-1 block of KDR channels in vascular smooth muscle have not been investigated 
previously. We used DPO-1 as a KV1.5-selective tool to test the supposition that KV1.5 
channels contribute to KDR current in porcine coronary smooth muscle. Moreover, we 
examined the effects of DPO-1 on KDR current kinetics and other biophysical properties 






Animals. The Institutional Animal Care and Use Committee at Indiana University 
School of Medicine approved the protocols. All methods conformed to regulations set 
forth by in the Guide for the Care and Use of Laboratory Animals (National Research 
Council, 2011). The hearts of anesthetized pigs, subjects of unrelated experiments, 
were fibrillated and removed. An epicardial segment of the right coronary artery was 
collected. 
Isolation of smooth muscle cells. A small portion (2-3 cm) of porcine right 
coronary artery was cleaned of adipose and adventitia in buffer containing (mM) 135 
NaCl, 5 KCl, 0.36 CaCl2, 1 MgCl2, 10 glucose, 10 HEPES, 5 Tris-Base, pH 7.4. The 
artery was transferred to a tube containing the same low Ca2+ HEPES buffer 
supplemented with (mg/ml) 2 collagenase, 1 elastase, 1 soybean trypsin inhibitor and 1 
bovine serum albumin. The tube was warmed to 37°C for 30-60 minutes. The artery 
was passed through the tip of a fire-polished Pasteur pipette to liberate single smooth 
muscle cells. Cell suspension was centrifuged at 400g for 5 min and the resulting pellet 
was resuspended in fresh low Ca2+ HEPES buffer. Cells were stored on ice and used 
within 8 hr.  
Electrophysiology. A drop of cell suspension was placed on an 8 mm diameter 
cover glass and cells were allowed 5-10 min to adhere. This cover glass was then 
moved to a recording chamber (volume 0.2-0.3 ml) mounted atop an inverted 
microscope. Cells were continuously superfused (2-3 ml/min) with a solution containing 
(mM) 135 Na-isethionate, 5 K-gluconate, 2 MnCl2, 1 MgCl2, 10 glucose, 10 HEPES, 5 
Tris-base, pH 7.4. Cells were approached with borosilicate pipettes having tip 
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resistances of 2-5 MΩ when filled a solution containing (mM) 140 K-gluconate, 1 MgCl2, 
3 Mg-ATP, 1 Na-GTP, 10 BAPTA, 10 HEPES, and 5 Tris, pH 7.1. KDR was isolated in 
whole-cell patch configurations because the pipette solution also contained penitrem A 
(1 μM) to block large conductance Ca2+ activated K+ channels, glibenclamide (10 μM) to 
block KATP channels, and BAPTA (10 mM), a Ca
2+ chelator. After achieving whole cell 
access, the appropriate voltage protocol was applied to examine specific aspects of 
porcine VSM delayed rectifier current and kinetics in the presence or absence of DPO-1 
in the bath solution. Currents were low-pass filtered at 1 kH and digitized at 5 kH.  
Statistics. Data are presented as the mean ± SE from n cells. Comparisons were 
made using 2-way repeated measures ANOVA (2RM-ANOVA; with Bonferroni post-hoc 
when appropriate) or paired t-tests as described. For all comparisons, p < 0.05 was 
considered statistically significant. Boltzmann fits were used to calculate the V1/2 of 
activation and inactivation curves. Mono-exponential fits were used to determine the 
kinetics of activation as well as the recovery from inactivation. Time-dependent 
inactivation was fit by a bi-exponential curve.   
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Results 
Smooth muscle KDR is inhibited by DPO-1. Fig. 1 shows concentration-dependent 
inhibition of KDR current by DPO-1 in smooth muscle cells isolated from the pig coronary 
artery. Results from two voltage protocols of dramatically different length are shown. 
Results from the first type of voltage protocol (Figs. 1A-D) were obtained with the typical 
400 ms duration template we have used previously (Dick et al., 2008). Results from the 
short voltage template allow one to appreciate that this a KDR current (note the fast 
activation, modest inactivation, deactivating tails, and shape of the I-V relationship). 
Inhibition of KDR current by DPO-1 was largely reversible upon washout (Fig. 1D). The 
second type of voltage protocol was more than 10-times longer in duration and lets one 
more fully appreciate the extent of time-dependent inactivation and even more dramatic 
effects of DPO-1 (Fig. 1E). By measuring current at the end of the test pulses in the 
shorter protocol and determining the effects of various concentrations of DPO-1, we 
calculated an IC50 of 212 ± 28 nM (Fig. 1F). Note that if current is measured at the end 
of the long voltage templates and effects are calculated, the apparent IC50 is 
approximately one log order lower (left shifted; Fig. 1F). We chose to use 1 μM DPO-1 
for the majority of the subsequent experiments as this concentration is above the 
calculated IC50 and produces substantial inhibition to study. 
 Fig. 2 shows activation and inactivation curves for KDR current in in smooth muscle 
cells from the porcine coronary artery. The activation curves were calculated from the 
peak current at the beginning of the various voltage steps (Figs. 2A and B). Current was 
divided by driving force (difference between test voltage and the equilibrium potential for 
K+) to calculate conductance (G). G was normalized to its maximum and plotted; these 
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activation curves increase from left to right in Fig. 1C. Inactivation was determined by 
measuring the fraction of available current at +20 mV following the various test 
potentials (expanded currents shown in Figs. 2Ai and 2Bi). The inactivation curves 
decrease from left to right in Fig. 1C. The area beneath the intersection of activation and 
inactivation curves represents the ‘voltage window’ for channel function. DPO-1 
significantly left shifted the activation curve (V1/2 was -4 ± 1 vs. -9 ± -1 mV before and 
after DPO-1 respectively). DPO-1 hyperpolarized the V1/2 of inactivation (V1/2 was -11 ± 
1 vs. -16 ± -1 mV before and after DPO-1 respectively). Moreover, the extent of 
inactivation was more complete in the presence of DPO-1 (74 ± 3 vs. 99 ± 1%). Overall, 
the effect of DPO-1 on the activation and inactivation curves is to reduce the area under 
them; therefore, limiting the voltage window for channel operation. 
Inhibition of KDR by DPO-1 is modestly voltage-dependent. Studies conducted on 
cloned KV1.5 indicate that DPO-1 blocks the current in a slightly voltage-dependent 
manner at potentials between 0 and 20 mV (Du et al., 2010). That is, block was more 
pronounced at more depolarized test potentials. Thus, we investigated the voltage-
dependence of block by 1 μM DPO-1 on KDR current in smooth muscle cells from the 
porcine coronary artery, voltage-dependent block is a hallmark of open state block. Fig. 
3 shows the effect of three concentrations of DPO-1 (0.1, 1, and 10 M) at voltages 
between -20 and +20 mV. This voltage range was chosen because it represents the 
steepest portion of the activation curve (dotted line in Fig. 3 is the Boltzman fit from Fig. 
2C). There is a modest voltage-dependent block by DPO-1. For example, inhibition by 
0.1 M doubles from 17 ± 3 to 36 ± 7% across this range of potentials (Fig. 3).  
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Inhibition of smooth muscle KDR by DPO-1 is frequency-dependent. Frequency-
dependent block of cloned KV1.5 with application of DPO-1 has been demonstrated (Du 
et al., 2010; Lagrutta et al., 2006). This is also known as use- or rate-dependent block 
and is an ideal characteristic for K+ channel inhibitors used to treat atrial fibrillation, as 
block becomes more effective as the rate of fibrillation increases. We show frequency-
dependent block of smooth muscle KDR by 1 μM DPO-1 (Fig. 4).  Membrane potential 
was stepped to +20 mV. Current was steady at the control rate of 0.2 Hz stimulation and 
the effect of DPO-1 reached steady state quickly. In the continued presence of DPO-1, 
increasing the frequency of stimulation to 1 and then 2 Hz produced significantly more 
inhibition of current. Reducing stimulation frequency back to 0.2 Hz relieved the greater 
degree of channel block. 
DPO-1 inhibits smooth muscle KDR in the open state. Open state block of cloned 
Kv1.5 by DPO-1 has been shown (Lagrutta et al., 2006). Specifically, Lagrutta et al. 
demonstrated that when cloned KV1.5 channels were treated with DPO-1, they would 
open and produce current to the untreated level instantaneously; however, when 
channels were open in the presence of drug, current rapidly decreased. Further, the 
degree of channel block increased to steady state over the next few trials. Fig. 5 shows 
what we describe as a ‘partial’ open state block of KDR by DPO-1 in coronary smooth 
muscle. The block is ‘partial’ open state block, because the current elicited by the first 
stimulus in the presence of DPO-1 is approximately 70% of the control, untreated peak. 
Current is not maximally blocked by DPO-1 until several more cycles of stimulation have 
occurred. Our results are more like those of Du et al. who showed that DPO-1 produced 
an initial instantaneous block of approximately 30% (Du et al., 2010). They suggested 
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that the initial instantaneous block might represent an extremely fast phase of open 
channel block followed by a second slow phase of block.  
DPO-1 affects the kinetics of KDR channels in smooth muscle. Figure 6 shows the 
effect of 1 μM DPO-1 on the activation time constant (τ) during a 350 ms +20 mV 
stimulus. DPO-1 induces a small but significant acceleration in activation τ (8.5 ± 1.1 vs.  
6.8 ± 0.6 ms; p < 0.05; Fig. 6C). Figure 6D shows that 1 μM DPO-1 abolished tail 
currents; therefore, deactivation kinetics could not be analyzed. This also precluded our 
inspection of tail current ‘crossover’, another indicator of open state block. 
DPO-1 significantly accelerated both the fast and slow components of 
inactivation (Figure 7C and D; control (fast) = 519 ± 74 ms vs. DPO-1 (fast) = 141 ± 10 
ms, control (slow) = 5,757 ± 1,071 ms vs. DPO-1 (slow) = 601 ± 222 ms; p < 0.05) 
during a five-second, +20 mV pulse (Figure 7A). The two components were fit 
simultaneously with a bi-exponential equation to produce a fast and slow inactivation τ 
in the presence and absence of 1 μM DPO-1 (Figure 7B). 
The recovery currents shown in Figure 8A were produced by a five-second +20 
mV conditioning pulse followed by a 300 ms test pulse. Each new test pulse was 
another 300 ms further from the conditioning pulse (denoted by Δt in the voltage 
template) in order to investigate the time for KDR to return after conditioned inactivation 
in the presence of DPO-1. DPO-1 reduced recovery currents and prolonged reactivation 
kinetics (320 ± 10 vs. 910 ± 107 ms; p< 0.05) extrapolated from this protocol.  
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Discussion 
The aim of the current study was to investigate porcine VSM KV channel kinetics 
and current inhibition when challenged with DPO-1 using whole cell voltage clamp 
electrophysiology and compare our findings to known effects of DPO-1 on cloned KV1.5 
patch analyses, thereby acknowledging both the specificity of DPO-1 for KV1.5 and the 
presence of KV1.5 in porcine coronary VSM. Our data suggest that DPO-1 blocks 
porcine coronary VSM IDR by shifting activation and inactivation currents to more 
polarized potentials and affects the kinetics of VSM IDR by binding in the open and 
inactivated state of KV1.5 containing channels. 
KV1.5 is a popular candidate for setting Em and therefore resting arterial tone 
especially in the pulmonary circulation due to its role in oxygen sensing (Archer et al., 
1998; Archer et al., 2004; Grissmer et al., 1994; Moudgil, Michelakis, & Archer, 2006). 
However, such a role for KV1.5 in other vascular beds, including the coronary 
circulation, is less established. Resting coronary flow is tightly regulated because the 
highly aerobic cardiac cells are in constant demand of supply, making IDR channels 
extremely important end effectors in maintaining sufficient resting tone. These end 
effectors, most likely KV1 channels, also provide hyperpolarizing currents to allow for 
coronary reserve under increased cardiac metabolic activity (Berwick et al., 2012).  
The molecular identities of the KV channels that drive IDR and therefore govern 
resting membrane potential and arterial tone remain unclear. This is due, in part, to a 
lack of specific pharmacology for individual KV channel members, however evidence for 
the KV1 subfamily has been supported through the use of correolide (Albarwani et al., 
2003; Archer et al., 2004; Cheong, Dedman, & Beech, 2001; Dick et al., 2008; Plane et 
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al., 2005), which will block all KV1 members. In arterial smooth muscle, the expression 
of KV1.5 has been observed in the microvasculature as well as in conduit-like arteries 
but so too has other KV channels, including other KV1 members (Plane et al., 2005; 
Thorneloe et al., 2001), making discerning which channels regulate arterial tone in 
specific vascular beds difficult to interpret.  
 The present study supports a role for KV1.5 in the regulation of coronary VSM based 
on similarities between our data in native VSM and other analyses of cloned KV1.5 
channel block by DPO-1. We report a dose-dependent block of porcine coronary VSM 
IDR by DPO-1 and a left shift in the voltage window of activation. Inhibition of VSM IDR 
was voltage and frequency dependent, hallmarks of open state block previously shown 
to be the mechanism of block by DPO-1 on cloned KV1.5. However, we report a ‘partial’ 
open state block that is not in line with inhibition of cloned KV1.5 by DPO-1. Our data 
indicate that the mechanism of DPO-1 inhibition of porcine coronary VSM IDR is by 
accelerating activation and inactivation kinetics and prolonging reactivation kinetics by 
binding in the open and inactivated state of channels containing KV1.5. These findings 
support the use of DPO-1 as a tool for investigating a role for KV1.5 in arterial smooth 
muscle. Furthermore, we suggest that the disparities between the present data and that 
of cloned KV1.5 support the hypothesis of heteromultimer KV channel complexes in 
arterial smooth muscle.  
Recently, KV1.5 specific drugs such as DPO-1 used in the present study, have 
been synthesized with the goal of treating atrial fibrillation by blocking the IKur 
component of the atrial action potential. Du et al. showed whole cell patch clamp of 
cloned human KV1.5 channels expressed in xenopus laevis oocytes and pulsed at +40 
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mV exhibited an IC50 of approximately 780 nM (Du et al., 2010). However, Lagrutta et al 
showed in the same expression system that the IC50 of DPO-1 for human cloned KV1.5 
is approximately 160 nM at a low stimulation frequency (Lagrutta et al., 2006). In our 
dose-response experiments of whole cell voltage clamp in porcine coronary VSM (Fig. 
1), we pulsed at +20 mV at a stimulation frequency of 0.2 Hz, which produced an IC50 
for DPO-1 of 212 ± 28 nM, which is in accordance with Lagrutta and colleagues. Block 
of porcine coronary VSM by DPO-1 is reversible upon washout and has been shown 
previously in these studies on cloned human KV1.5.  
In many studies investigating open state block of KV1.5, drugs did not influence 
the voltage sensitivity with regard to activation (Du et al., 2010; Jeong, Choi, & Hahn, 
2013; Jeong, Choi, Yoon, & Hahn, 2012; Jeong, Yoon, & Hahn, 2012) yet we report a 
significant left shift at 0 and -10 mV in coronary VSM whole cell patch clamp 
experiments (Fig 2), which would indicate an increase in voltage sensitivity associated 
with agonists of voltage sensitive channels. While this may be an artifact of our 
calculations in correcting for driving force from step potentials in lieu of abolished tail 
currents, we suggest that DPO-1 exhibits a dose dependent “foot in the door” effect as 
an open channel blocker. Du et al. show a left shift of V1/2 activation from -3.7 mV to -
8.1 mV with application of 30 μM DPO-1. Similarly, in our studies using 1 μM DPO-1, a 
shift of the V1/2 activation from -3.8 mV to -9.3 mV was observed. This data supports the 
specificity of DPO-1 for KV1.5 in porcine coronary VSM and is similar to activation 
curves investigating drug-induced tail current crossover of cloned KV1.5 (Du et al., 
2010). However, we are aware that we cannot show evidence of the “foot in the door” 
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effect without first observing tail current crossover (Fig. 6) and plan to repeat these 
experiments with submicromolar concentrations of DPO-1.  
 Inactivation curves were produced by a two-pulse protocol to observe the 
inactivation currents (see the Figure 2 legend for further details). Because our 
experiments were conducted in native cells, a variety of KV channel inactivating 
influences are present and therefore the control inactivation curve does not match KV1.5 
positive to +10 mV. The application of 1 μM DPO-1 significantly left shifts the V1/2 from -
10.9 mV to -14.6 mV and induces complete inactivation by approximately +10 mV. The 
shift of inactivation to more polarized potentials is in accordance with many other KV1.5 
open state blockers including lobeline, dapoxetine, and pergolide tested in a series of 
publications by Hahn and colleagues (Jeong et al., 2013; Jeong, Choi, et al., 2012; 
Jeong, Yoon, et al., 2012). In addition, DPO-1 has been shown to interact with at least 
six residues of the S4 voltage-sensing segment of activated KV1.5 channels (Du et al., 
2010), supporting the observed effects in voltage sensitive curves and our hypothesis 
that DPO-1 is inhibiting KV1.5 channels in porcine coronary VSM. Together, activation 
and inactivation curves show that DPO-1 shifts, and in our two-pulse protocol reduces, 
the voltage window of activation to more polarized potentials (Fig.2), suggesting that 
DPO-1 may be inhibiting KV1.5 channels of porcine coronary VSM in the open and 
inactivated states.  
 The voltage dependent block of cloned KV1.5 and IKur by DPO-1 is well established 
(Du et al., 2010; Lagrutta et al., 2006) and was the basis for investigating voltage 
dependency of DPO-1 in native porcine coronary VSM. In addition, our observations of 
the decreased and left shifted voltage window of activation (Fig. 2) prompted our 
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investigation of coronary VSM voltage dependent block by DPO-1. DPO-1 produced a 
similar, although left shifted, window of voltage dependent inhibition of coronary VSM 
(Fig. 3) as compared to previous work by Du et al. where the voltage window of block by 
300 nM DPO-1 was 0 mV to +20 mV in cloned human KV1.5 (Du et al., 2010). We 
suggest this difference in voltage window block may be due to the concentrations used, 
however, we did not analyze our lower concentration (100 nM) at more positive 
potentials where we may have observed a similar result to other studies. Our finding 
that 1 μM DPO-1 exhibits a voltage dependent block in the window of -20 mV to 0 mV is 
in line with the voltage window of activation produced by DPO-1 (approximately -30 mV 
to +10 mV) in the present study (Fig. 2). KV1.5 is activated in this range of potentials. 
Therefore, we interpret the block by DPO-1 in the activation window of coronary VSM 
IDR as corresponding to block of KV1.5, which supports the use of DPO-1 to investigate 
KV1.5 channels in native coronary VSM.  
 Frequency dependent block by DPO-1 on cloned KV1.5 channels has also been 
shown to increase the potency of inhibition (Du et al., 2010; Lagrutta et al., 2006). We 
show a frequency dependent block by DPO-1 in porcine coronary VSM (Fig. 4) similar 
to that which Lagrutta et al. and Du et al. showed on cloned human KV1.5 expressed in 
x. laevis oocytes. In the present study, we used 1 μM DPO-1 and a maximum 
stimulation frequency of 2 Hz to show the frequency dependent block of coronary VSM 
IDR. In the study by Du et al., 300 nM DPO-1 reduced KV1.5 currents at only 0.66 Hz 
beyond control currents at 3 Hz. In comparison to our data in native smooth muscle, 1 
μM DPO-1 at a stimulation frequency of .2 Hz does not significantly reduce currents 
beyond control currents stimulated at 2 Hz. Lagrutta et al. show that 1 μM DPO-1 
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abolishes KV1.5 current at 1 Hz. Under the same conditions in our study, we observe 
>60% block by DPO-1. We interpret the differences between our investigation of DPO-1 
on native coronary smooth muscle and that of the studies examining cloned KV1.5 to 
mean that 1 μM DPO-1 is specific to KV1.5 over other KV currents present in the native 
system i.e. 1 μM DPO-1 does not reduce current to zero at 2 Hz.  
 We suggest that the voltage and frequency dependent inhibition observed in the 
present study is due to block of KV1.5 currents and that is supported by studies 
investigating the atrial action potential, including selectivity for IKur over Ito, IK1, IKr, IKs 
(Lagrutta et al., 2006). However, DPO-1 has recently been shown to inhibit Kv1.3 
channels, also expressed in arterial smooth muscle, in human T cells (Zhao et al., 
2013). While we used a concentration less than the calculated IC50 of 2-3 μM in the 
study on KV1.3, we acknowledge that we may be inhibiting other KV1 channels at 1 μM 
DPO-1. Currently, a more collective knowledge regarding the effect of DPO-1 on non-
Kv1.5 KV1 delayed rectifier current is lacking, however, it remains a useful tool for the 
investigation of VSM delayed rectifying current. Furthermore, it is our supposition that at 
lesser concentrations DPO-1 is an appropriate tool to exclusively study KV1.5 in native 
cells including VSM. 
 Open state block of KV channels by a variety of drugs is well established and DPO-1 
exhibits such a mechanism on KV1.5 as supported by the voltage and frequency 
dependent block, as well as tail current crossover, shown in previous studies (Du et al., 
2010; Lagrutta et al., 2006). A more direct approach for investigating the open state 
block of human cloned KV1.5 by DPO-1 was performed by Lagrutta et al. in outside-out 
patch experiments. Application of 1 μM DPO-1 for five minutes after recording control 
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currents revealed that the subsequent pulse reached control peak current levels. 
Additional pulses showed complete block by DPO-1. We repeated this experiment in 
whole cell patches of porcine coronary VSM in the present study (Fig. 5). After five 
minutes incubation with 1 μM DPO-1 we observed an approximately 30% block from 
control currents with the initial pulse, which is at odds with Lagrutta et al. in cloned 
KV1.5 outside-out patches. Furthermore, the subsequent pulses did not immediately 
reach full block as in the comparison study. While these differences between our current 
study and those conducted by Lagrutta et al. are unlikely due to patch configurations, 
we do however acknowledge the possibility of native β auxiliary subunits or 
heterotetrameric complexes containing KV1.5. Evidence for such complexes have been 
supported in a series of publications by Cole and colleagues and suggests that the 
underlying molecular identity of IDR conducting KV channels in arterial smooth muscle is 
likely that of KV1.5 and KV1.2 containing channels (Kerr et al., 2001; Plane et al., 2005; 
Thorneloe et al., 2001). It could therefore be possible that heterotetrameric channels 
could change the interaction of DPO-1 with KV1.5 and thusly modify the conditions of 
open state block, complicating our investigation of open state block by DPO-1 in native 
arterial smooth muscle. Our group is considering further examination of the effects of 
DPO-1 on cloned KV1.5-KV1.2 complexes. 
 The effects of DPO-1 on porcine coronary VSM IDR kinetics were extrapolated from 
whole-cell patch clamp data in the present study and include activation, fast and slow 
inactivation, and recovery from inactivation. To our knowledge, the effect of DPO-1 on 
KV1.5 activation τ has not been investigated. We show that DPO-1 accelerates the 
activation τ of porcine coronary VSM (Fig. 6). Similarly, studies investigating the effects 
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of polyunsaturated fatty acids on KV1.5 have shown increased activation kinetics 
coupled to the inhibition of current (Guizy et al., 2008; McKay & Worley, 2001). These 
studies suggest that polyunsaturated fatty acids may be reducing the free energy 
needed for KV1.5 to open thus accelerating channel opening. This would correspond to 
a left shift in the V1/2, and may explain the mechanism as to how DPO-1 is accelerating 
activation of IDR channels in our study. We also observed accelerated components of 
inactivation. Co-expression of KVβ1.3 with KV1.5 results in a fast and slow component of 
inactivation (Tipparaju et al., 2012) and this association is plausible as KVβ1.3 is 
expressed in arterial smooth muscle (Thorneloe et al., 2001). We successfully fit a 
biexponential function to the traces in the current study during inactivation of KV 
channels, perhaps supporting evidence of auxiliary β subunit association with KV1.5α 
pore. Both the fast and slow τ of inactivation were robustly and significantly accelerated 
by DPO-1 and we suggest this to be the prominent mechanism of VSM IDR inhibition. 
KV1.5 exhibits a P/C type inactivation where N-terminal T-domains are expected to 
promote slow inactivation of the channel (Kurata et al., 2002). Modulation of residues of 
the T-domain results in the switching from P/C to U-type inactivation (Kurata, Doerksen, 
Eldstrom, Rezazadeh, & Fedida, 2005). While the expected residues of DPO-1 
interaction with KV1.5 have been shown to be in the S4 voltage-sensing segment (Du et 
al., 2010), the left shift of inactivation curves upon application of DPO-1 also appears to 
mimic T-domain modulation. Based on this observation, we hypothesize a mode of 
inhibition by DPO-1 where slow inactivation components of the T-domain are prevented 
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Figure 3.1 DPO-1 blocks KDR channels in a concentration-dependent manner. Panel A 
contains KDR current traces from a representative coronary smooth muscle cell when 
depolarized to +20 mV. This 5 s trace illustrates the time-dependent inactivation of KDR 
current. Panel B shows group data (n = 5) demonstrating the concentration-dependent 
effect of DPO-1 to inhibit KDR current. Note that the effect of DPO-1 is largely reversible 







Figure 3.2 DPO-1 reduces the voltage window for the function of KDR channels. Panels 
A and B contain current traces from a representative coronary smooth muscle cell 
before and after treatment with 1 μM DPO-1. The voltage protocol was designed to 
demonstrate voltage-dependent activation and inactivation. Activation was determined 
from the peak current near the beginning of the voltage stimuli (current was converted 
to conductance by considering voltage and the equilibrium potential for K+). The extent 
of voltage-dependent inactivation was determined by measuring current at the end of 
the voltage template when potential was +20 mV. Panels Ai and Bi show the current at 
+20 mV on an expanded scale. Panel C contains the activation curves (rising from left 
to right) and inactivation curves (falling from left to right) before and after treatment with 
DPO-1. Note that DPO-1 produced a slight hyperpolarizing shift in the activation curve, 
which would serve to increase the voltage window. Importantly, however, this effect is 
overshadowed by a dramatic rightward shift and downward shift in the inactivation curve 
caused by DPO-1. That is, DPO-1 caused KDR channels to inactivate at more negative 






Figure 3.3 Modest voltage-dependence in the block of KDR channels by DPO-1. The 
percent inhibition for different concentrations (bottom to top: 100 nM, 1 μM, and 10 μM) 
of DPO-1 is plotted on the activation curve of porcine coronary KDR. Both 1 μM and 10 
μM DPO-1, but not 100 nM DPO-1, show steep inhibition in the voltage window of -20 to 
+20 mV. The curvilinear response at these concentrations indicates voltage dependent 





Figure 3.4 The degree to which DPO-1 inhibits KDR depends on stimulation rate. 
Increasing the frequency of +20 mV pulse appears to increase the ability of DPO-1 to 
block porcine KDR. This is in accordance with an open state block mechanism 





Figure 3.5 The block by DPO-1 requires, to some degree, that KDR channels open. We 
repeated the experiment performed by Lagrutta et al. in whole-cell patches of smooth 
muscle cells isolated from porcine coronary artery. Our data indicate that 1 μM DPO-1 
blocks a population of KDR channels in the open state. However, we do not observe a 
return to peak current after the initial stimulus following DPO-1 application suggesting a 





Figure 3.6 DPO-1 appears to increase the rate of time-dependent activation and 
abolishes KDR channel deactivation. Panel A shows a representative trace of KDR before 
and after DPO-1 application during a +20 mV pulse. KDR activation was fitted with a 
mono-exponential function to extrapolate the kinetics of channel opening. Panel B 
shows the representative (τ = 13.5 vs. 9.6 ms) and normalized fits from Panel A. Panel 
C is the group data and shows 1 μM DPO-1 accelerates activation kinetics (p < 0.05). 
This concentration of DPO-1 abolishes tail currents and therefore deactivation could not 





Figure 3.7 DPO-1 accelerates both components of time-dependent inactivation. Panel A 
shows a representative trace of a 5 second protocol used to observe the inactivation of 
porcine coronary smooth muscle KDR before and after 1 μM DPO-1. KDR inactivation 






Figure 3.8 DPO-1 slows the recovery from inactivation. Panel A shows a representative 
trace where the voltage protocol allowed the investigation of the recovery from 
inactivation before and after 1 μM DPO-1. Panel B shows the group data normalized to 
control currents and fit with a mono-exponential function to determine the kinetics of 
recovery (320 ±  vs. 876 ±  ms). Panel C shows the within group normalized data and 
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We demonstrated previously that BK (KCa1.1) channel activity (NPo) increases in 
response to bisphenol A (BPA). Moreover, BK channels containing regulatory 1 
subunits were more sensitive to the stimulatory effect of BPA. How BPA increases BK 
channel NPo remains mostly unknown. Estradiol activates BK channels by binding to an 
extracellular site, but neither the existence nor location of a BPA binding site has been 
demonstrated. We tested the hypothesis that an extracellular binding site is responsible 
for activation of BK channels by BPA. We synthesized membrane-impermeant BPA-
monosulfate (BPA-MS) and used patch clamp electrophysiology to study channels 
composed of  or + 1 subunits in cell-attached (C-A), whole-cell (W-C), and inside-
out (I-O) patches. In C-A patches, bath application of BPA-MS (100 M) had no effect 
on the NPo of BK channels, regardless of their subunit composition. Importantly, 
however, subsequent addition of membrane-permeant BPA (100 M) increased the NPo 
of both  and + 1 channels in C-A patches. The C-A data indicate that in order to 
alter BK channel NPo, BPA must interact with the channel itself (or some closely 
associated partner) and diffusible messengers are not involved. In W-C patches, 100 
M BPA-MS activated current in cells expressing  subunits, whereas cells expressing 
+ 1 subunits responded similarly to a log-order lower concentration (10 M). The 
W-C data suggest that an extracellular activation site exists, but do not eliminate the 
possibility that an intracellular site may also be present. In I-O patches, where the 
cytoplasmic face was exposed to the bath, BPA-MS had no effect on the NPo of BK  
subunits, but BPA increased it. BPA-MS increased the NPo of + 1 channels in I-O 
patches, but not as much as BPA. We conclude that BPA activates BK  via an 
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extracellular site and that BPA-sensitivity is increased by the 1 subunit, which may also 
constitute part of an intracellular binding site. 
 




Large conductance Ca2+/voltage-activated K+ (BK) channels are expressed in the 
plasma membranes and intracellular organelles of numerous cell types.(Singh, Stefani, 
& Toro, 2012) BK channels are important physiological regulators whose functions are 
impacted by and/or underlie disease.(Du et al., 2005; McGahon, Zhang, Scholfield, 
Curtis, & McGeown, 2007) These channels are composed of pore-forming  subunits 
encoded by the KCNMA1 gene.(Butler, Tsunoda, McCobb, Wei, & Salkoff, 1993) The 
minimal BK channel is an assembly of 4  subunits around a central axis. Each  
subunit has an extracellular N-terminus, 7 transmembrane segments, and an 
intracellular C-terminus containing numerous regulatory domains and sites.(Hill, Yang, 
Ella, Davis, & Braun, 2010) -only tetramers are fully functional K+-selective channels 
with inherent Ca2+- and voltage-sensitivity. Variations in  subunit properties result from 
alternative splicing of KCNMA1.(Soom, Gessner, Heuer, Hoshi, & Heinemann, 2008) 
However, a variety of important post-translational modifications also regulate BK 
channel properties, including their trafficking and anchoring to the membrane.(Kyle, 
Hurst, Swayze, Sheng, & Braun, 2013; Tian, McClafferty, Knaus, Ruth, & Shipston, 
2012) Other differences in BK channels can be due to co-assembly with regulatory  
subunits, 4 of which have been identified.(Sun, Zaydman, & Cui, 2012)  subunits can 
dramatically change channel properties including gating kinetics, Ca2+/voltage-
sensitivity, and pharmacology.(Sweet & Cox, 2009) Interestingly, it has been 
demonstrated recently that the N-terminus of intermediate conductance Ca2+-activated 
K+ channels reduces BK channel NPo by the same open channel block underlying 2- 
and 3-induced inactivation.(Thompson & Begenisich, 2009)  subunits can also 
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influence the response of BK channels to pharmacological blockers and 
openers.(Asano et al., 2012; Bukiya, Liu, Toro, & Dopico, 2007; Dick, Rossow, Smirnov, 
Horowitz, & Sanders, 2001; Meera, Wallner, & Toro, 2000) 
BK channels are activated by estradiol (Valverde et al., 1999) and 
xenoestrogens.(Dick, Hunter, & Sanders, 2002; Dick et al., 2001; Dick & Sanders, 2001) 
Regulation by estrogenic substances, in multiple cases, involves β subunits.(Dick et al., 
2001; Dick & Sanders, 2001; Valverde et al., 1999) We demonstrated previously that 
BPA increases the open probability (NPo) of BK channels without affecting single 
channel conductance.(Asano, Tune, & Dick, 2010) BPA appears to have less of an 
effect on BK channels lacking the 1 subunit, as a 10-fold higher concentration of BPA 
was needed to activate BK  subunits alone.(Asano et al., 2010) Thus, effects of BPA, 
like those of other xenoestrogens, seem to be modulated by  subunits. However, a 
particular extracellular or intracellular binding site for the molecule has not been 
identified; BPA is lipophilic and it would be reasonable to suggest sites on either side of 
the membrane. It is possible that BPA binds to the  subunit, but this interaction is 
made much more efficient by addition of the 1 subunit.(Asano et al., 2010) Another 
possibility may be that two different BPA binding sites exist when the 
present (Asano et al., 2010) Whether these sites are intracellular, extracellular, or both 
remains unclear. In this study, we test the hypothesis that an extracellular binding site is 
responsible for activation of BK channels by BPA. In order to examine this possibility, 
we synthesized membrane-impermeant BPA-monosulfate (BPA-MS). This novel 
reagent allows us to determine whether an intracellular or extracellular binding site 
exists (under the presumptions that BPA-MS: 1) can bind to the same site(s) as BPA 
 130 
and 2) similarly increase channel activity). W-C, C-A, and I-O recordings were made on 




We recorded BK currents in AD 293 cells expressing  or  + 1 subunits (Fig. 
1). Our goal was to determine whether BPA-MS, a membrane-impermeant derivative of 
BPA, increased whole-cell BK current. Further, if BPA-MS were to have an effect, we 
were interested in determining whether the presence of the 1 subunit influenced it. In 
cells expressing BK  subunits, whole-cell current was unaffected by 10 M BPA-MS 
(Fig. 1A and B). Specifically, in cells expressing  subunits alone, current in the 
presence of BPA-MS was 106 ± 4% of control (n = 5). There was no BK current in non-
transfected cells (data not shown) and the current in transfected cells was identified as 
BK through its sensitivity to 1 M penitrem A (93 ± 4% block).(Asano et al., 2012) In 
cells expressing BK  + 1 subunits, current magnitude was increased by 10 M BPA-
MS (Fig. 1C and D). Specifically, at +100 mV, BPA-MS increased current 34 ± 4% (an 
increase of 712 ± 103 pA; n = 7) when the 1 subunit was present. These data are very 
much like what we reported previously for the effect of BPA on whole-cell BK current 
and the role of the 1 subunit (ref. (Asano et al., 2010)); however, these experiments 
with BPA-MS further indicate that the stimulatory effect of BPA is probably mediated, at 
least in part, by an extracellular binding site. 
In our previous report, we demonstrated that a 10-fold higher concentration of 
BPA (100 M) could activate BK channels composed of  subunits alone.(Asano et al., 
2010) Thus, in the present study, we determined whether a log order higher 
concentration of membrane-impermeant BPA-MS (100 M) could also activate BK  
subunits (Fig 2). Bath application of 100 M BPA-MS to W-C patches increased BK  
current (Fig. 2A). Specifically, at +100 mV, 100 M BPA-MS increased BK  current 36 
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± 4% (an increase of 1151 ± 187 pA; n = 6). These data support what we demonstrated 
previously regarding the role of the 1 subunit in determining sensitivity to BPA. Further, 
these data lead us to suggest that the lower affinity site for activation of BK  by 
BPA/BPA-MS is extracellular. 
We performed additional W-C experiments to further characterize the 
concentration-dependence of BPA-MS effects (Fig. 3). In cells expressing BK  + 1 
subunits, BPA-MS increased current in a concentration-dependent manner (Fig. 3A). 
The increase in BK  + 1 current by BPA-MS (Fig. 3B) was qualitatively similar to 
effects of BPA we reported previously.(Asano et al., 2010)  Quantitatively, in cells 
expressing BK  + 1 subunits, the magnitude of BPA-MS-activated current was less 
than that elicited by BPA (Fig. 3B). However, the current activated by BPA-MS was 
greater in cells expressing BK  + 1 subunits than cells expressing BK  alone (Fig. 
3B). These data may indicate that effects of BPA-MS are less than BPA because 
intracellular and extracellular binding sites exist, but bath-applied, membrane-
impermeant BPA-MS is restricted to acting on only the extracellular site. Further, the 
data may indicate that BPA-MS is a more potent and efficacious agonist of BK channels 
when the 1 subunit is present.    
Our next set of experiments was designed to demonstrate that BPA-MS is, 
indeed, membrane-impermeant. Our rationale was that: a) the W-C data suggest a low 
affinity extracellular site for BPA exists; 2) BPA is membrane-permeant and should 
activate channels in C-A patches through extracellular sites and intracellular sites (if any 
exist); 3) BPA-MS, if membrane-impermeant, should be unable to activate BK channels 
(  or  + 1) physically isolated from the test solutions by the pipette glass and plasma 
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membrane. Results from C-A patches are shown in Fig. 4. In C-A patches on cells 
expressing BK  + 1, adding 10 M BPA-MS to the bath had no effect on NPo (Fig. 
4A). In contrast, adding 10 M BPA to the bath increased NPo 695 ± 325% (n = 8; Fig. 
4A and B). We performed additional experiments with a higher concentration of BPA-
MS (100 M) to more rigorously test whether it might cross the membrane and activate 
channels. In C-A patches on cells expressing BK  + 1, adding 100 M BPA-MS to the 
bath had no effect on channel activity (NPo was 132 ± 9% of control; n = 4). In contrast, 
adding 100 M BPA to bath solution in these experiments increased NPo 521 ± 154% (p 
< 0.05). These data demonstrating differential effects of BPA and BPA-MS on NPo 
reassure us that the latter is likely membrane-impermeant (and that our preparation of 
BPA-MS is not contaminated with significant amounts of BPA). Further, the data also 
lead us to suggest that AD 293 cells do not metabolize BPA-MS by defsulfation to 
produce BPA, as can be observed in cells expressing estrone sulfatase activity.(Stowell 
et al., 2006)  
We excised I-O patches from cells expressing BK channels composed of  or  
+ 1 subunits and determined the effect of bath-applied BPA-MS (Fig. 5). Our goal was 
to determine whether BPA-MS increased BK channel NPo at the intracellular face of the 
membrane. Further, if BPA-MS were to activate BK channels, we were interested in 
determining whether the presence of the 1 subunit influenced this effect. In I-O 
patches from cells expressing BK  alone, adding 100 M BPA-MS to the bath had no 
significant effect on NPo (156 ± 15% of control, n = 8; Fig. 5A and B). However, adding 
100 M BPA to the bath increased NPo 462 ± 147% (Fig. 5A and B). The response to 
intracellular BPA-MS was much different when BK channels contained the 1 subunit 
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(Fig. 5C). In I-O patches from cells expressing BK  + 1 subunits, adding 10 M BPA-
MS to the bath increased NPo 403 ± 97% (n = 15; Fig. 5C and D). Replacing BPA-MS 
with BPA increased NPo 910 ± 247% (Fig. 5C and D). Thus, BPA-MS can activate BK 
channels from the cytoplasmic face of the membrane only if the 1 subunit is present. 
These data lead us to suggest that the 1 subunit may comprise or complete an 
intracellular binding site for BPA. 
Until this point, all of our single channel experiments had been performed at only 
one voltage, +40 mV on the membrane. We were interested in determining the effect of 
BPA-MS on BK channel activity at a variety of voltages. Rather than repeat the 
experiments outlined above at constant holding potentials, we opted to construct 
activation curves for channels in I-O patches (Fig. 6). Thus, I-O patches were excised 
from cells expressing BK  or  + 1 and stepped to voltages between -40 and +140 
mV in symmetrical 140 mM K+ with 500 nM Ca2+. Currents were recorded under control 
conditions and with bath application of 100 M BPA-MS or 100 M BPA. Conductance 
(G) was calculated by dividing current by voltage; G was then normalized to the 
maximum for each patch (Gmax). When BK channels were composed of  subunits 
alone, BPA-MS had no effect on the voltage at which 50% of the channels were 
activated (V½ = 98 ± 2 and 98 ± 2 mV, n = 8; Fig. 6A-C). However, bath application of 
membrane-permeant BPA did increase channel activity at lower voltages (V½ = 82 ± 2 
mV). The BPA-induced hyperpolarizing shift was parallel, as the slope factor (k) was not 
significantly altered (16 ± 2 for all 3 curves). When BK channels contained the 1 
subunit, BPA-MS hyperpolarized the V½ (from 54 ± 2 to 34 ± 2 mV, n = 12; Fig. 6D-F). 
Bath application of membrane-permeant BPA increased channel activity further (V½ = 
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17 ± 3 mV). The BPA-induced hyperpolarizing shift was parallel, as k was not 
significantly altered (20 ± 2, 18 ± 2, and 22 ± 3 for control, BPA-MS, and BPA, 
respectively). Data from these activation curves support the single channel experiments 
in that: a) BPA, but not BPA-MS, activates BK  in I-O patches; b) in I-O patches, BPA-
MS activates BK channels containing the 1 subunit; c) membrane-permeant BPA 
activates BK  + 1 more than BPA-MS. Further, these data indicate that BPA and 
BPA-MS activate BK channels over a much wider range of voltages than we had 
examined in the previous experiments. 
Effects of BPA-MS on NPo are reversible (Fig. 7). The results in Fig. 7A are from 
a single I-O patch pulled from a cell expressing BK  + 1. NPo at +40 mV is plotted vs. 
time. BPA-MS increased channel activity, but channel activity returned to baseline upon 
washout. Thus, effects of BPA-MS mediated at the intracellular face of the membrane 
are reversible. Data from a representative W-C experiment are shown in Figs. 7B and 
C. These data indicate that effect of BPA-MS to increase BK current from extracellular 
face of the membrane is also reversible. We reported previously that BPA had no effect 
on BK channel unitary conductance.(Asano et al., 2010) It appears that BPA-MS, at 
least from the cytoplasmic side, does not alter unitary conductance either (see Fig. 5; 
also a lack of effect can be inferred from Fig. 6, where G is unaffected). However, to 
determine whether BPA-MS affected unitary conductance from the extracellular side of 
the membrane, we performed experiments in outside-out patches. Extracelllular BPA-
MS had no effect on BK channel amplitude, as channels demonstrated conductances of 
240 ± 10 and 241 ± 10 pS before and during exposure to 100 M BPA-MS, respectively 
(n = 4). 
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Discussion 
BPA, a component of polycarbonate plastic used in food and beverage 
containers, is an estrogenic endocrine disruptor found in the urine of >95% of 
Americans.(Calafat, Ye, Wong, Reidy, & Needham, 2008) We and others have 
demonstrated that a wide variety of ion channels (GABA receptors, nicotinic receptors, 
voltage-gated Na+ channels, voltage-gated Ca2+ channels, and BK channels) are 
targets of BPA. (Aoshima, Hossain, Imamura, & Shingai, 2001; Asano et al., 2010; Choi 
et al., 2007; Deutschmann, Hans, Meyer, Haberlein, & Swandulla, 2013; Nakazawa & 
Ohno, 2001; O'Reilly et al., 2012; Wang et al., 2011) Specifically, we have shown 
previously that BPA activates BK channels; however, channels containing regulatory 1 
subunits were approximately one log-order more sensitive to BPA.(Asano et al., 2010) 
In the present study, we tested the hypothesis that an extracellular binding site is 
responsible for activation of BK channels by BPA. This hypothesis was based on 
previous studies indicating that membrane-impermeant estrogen and estrogen receptor 
modulators activate BK channels by binding to an extracellular site.(Dick et al., 2002; 
Valverde et al., 1999) In order to test the hypothesis, we synthesized membrane-
impermeant BPA-MS and used patch clamp electrophysiology to study BK channels 
composed of  or + 1 subunits in C-A, W-C, and I-O patches. Our 4 major findings 
included: 1) BK  was activated by extracellular 100 M BPA-MS (Fig. 2); 2) the 1 
subunit made BK channels 10x more sensitive to extracellular BPA-MS (Fig. 1); 3) BK 
channels containing the 1 subunit were activated by intracellular BPA-MS, whereas  
only BK channels were not (Figs. 5 and 6); and 4) BPA was a more efficacious activator 
of BK + 1 than was BPA-MS (Fig. 3, 5, and 6). These data lead us to conclude that 
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the hypothesis is supported. That is, an extracellular binding site appears to be 
responsible, at least in part, for the activation of BK channels by BPA (and BPA-MS). 
Importantly, however, we did not predict that BPA-MS would activate BK + 1 
channels from the cytoplasmic face of the membrane or that a difference would exist in 
the magnitude of NPo responses to intracellular BPA and BPA-MS. These surprising 
findings lead us to suggest that the 1 subunit may also constitute at least a part of an 
intracellular binding site. 
The idea that that the 1 subunit may contribute to an intracellular binding site 
gains support from a substantial and integrative body of work from Dopico and 
colleagues on lithocholate, a cholane-derived steroid.(Bukiya et al., 2007; Bukiya et al., 
2013; Bukiya, Singh, Parrill, & Dopico, 2011; Bukiya, Vaithianathan, Toro, & Dopico, 
2008, 2009) Lithocholate activates smooth muscle BK channels from wild type, but not 
1 subunit knockout mice.(Bukiya et al., 2007) The second transmembrane domain of 
1 is critical for conferring sensitivity to lithocholate, especially residues T169, L172, 
and L173.(Bukiya et al., 2011; Bukiya et al., 2008, 2009) Membrane topology and 
computational modeling place these 3 residues in an intracellular-facing region where 
hydrogen bonding and hydrophobic interactions form a binding site. Whether this pocket 
is responsible for our observed effects of intracellular BPA on BK channels remains to 
be determined. However, this is our prediction as, this site also mediates responses to 
the nonsteroidal BK channel opener HENA (3-hydroxyolean-12-en-30-oate).(Bukiya et 
al., 2013) 
There is a clear case for wanting to understand the effects of lithocholate on BK 
channels, as bile acids can be found in the circulation high micromolar concentrations, 
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dilate arterioles (including ileal vessels, which facilitates adsorption of fat), and reduce 
blood pressure.(Bomzon & Ljubuncic, 1995) There is no such thing as a “physiological” 
level of BPA, so the need to understand the effects of BPA on ion channels comes from 
a toxicology point of view. BPA, with an annual production over six billion pounds, is one 
of the highest volume chemicals worldwide.(Vandenberg, Maffini, Sonnenschein, Rubin, 
& Soto, 2009) BPA is used to manufacture polycarbonate plastics, including those for 
food and beverage containers, which represent the major sources of exposure for most 
people. In fact, the body fluids of >95% of Americans test positive for BPA.(Calafat et 
al., 2008) This may be cause for concern, because BPA has been identified as an 
estrogenic endocrine disruptor. Insight into the biologically relevant mechanisms of BPA 
began in 1993 with the observation that it was released from polycarbonate plastics 
during autoclaving and interfered with estrogen binding proteins in yeast.(Krishnan, 
Stathis, Permuth, Tokes, & Feldman, 1993) The structure of BPA allows it to bind 
receptors in the human body normally occupied by steroids to exert its anti-androgenic 
and estrogenic effects. BPA interacts with nuclear estrogen receptors (ER) α and β, 
albeit with low affinity.(Matthews, Twomey, & Zacharewski, 2000) By doing so, BPA 
exerts its nuclear (i.e., genomic) effects. BPA also possesses the ability to alter 
estrogen signaling through two less conventional pathways.(Nadal et al., 2000) 
Specifically, BPA can bind to membrane-bound ERα and a G protein-coupled ER 
(GPER).(Bouskine, Nebout, Brucker-Davis, Benahmed, & Fenichel, 2009) Both 
membrane-bound ERα and GPER couple to non-genomic signaling pathways that have 
multiple effects, most of which have only recently become appreciated.(Watson, 
Bulayeva, Wozniak, & Alyea, 2007) Ion channels are also targets for BPA 
 139 
effects.(Aoshima et al., 2001; Asano et al., 2010; Choi et al., 2007; Deutschmann et al., 
2013; Nakazawa & Ohno, 2001; O'Reilly et al., 2012; Wang et al., 2011) Whether these 
ion channel effects contribute to the association of BPA exposure with disease remains 
to be determined.(Lang et al., 2008) 
 The first identified ion channel target for BPA was recombinant GABAA receptors 
in 2001.(Aoshima et al., 2001) Complex effects were demonstrated, as low 
concentrations of BPA potentiated responses to low concentrations of GABA, but high 
concentrations of BPA inhibited GABA responses. Later, BPA was shown to elicit 
postsynaptic current in CA3 pyramidal neurons, likely mediated by GABAA 
channels.(Choi et al., 2007) The activation of GABAA channels by BPA may be 
interestingly related to mechanisms responsible for BK channel activation by BPA, as 
both channels are also potentiated by ethanol.(Liu, Bukiya, Kuntamallappanavar, Singh, 
& Dopico, 2013) Effects of BPA on the other identified ion channel targets share a 
common feature, as BPA uniformly inhibits a variety of voltage-gated Na+ channels 
(tetrodotoxin-sensitive and -resistant) and voltage-gated Ca2+ channels (L-, N-, P/Q-, 
and T-type).(Deutschmann et al., 2013; O'Reilly et al., 2012; Wang et al., 2011) In 
contrast, we show that BPA activates BK channels, which, interestingly, share some 
structural and regulatory features of voltage-gated Na+ and Ca2+ channels. 
Whether these non-genomic effects of BPA on BK channels  
(as well as other ion channels) are relevant to human disease remains to be 
determined. Genomic effects of BPA ion channel expression are also possible and merit 
investigation. The present study, however, focused on non-genomic mechanisms and 
we have shown that 100 M BPA-MS activated current in cells expressing  subunits, 
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whereas cells expressing + 1 subunits responded equally to 10 M BPA-MS. The 
W-C data suggest that an extracellular site exists for BPA on the  subunit. Our data 
show that in I-O patches, where the cytoplasmic face was exposed to the bath, BPA-MS 
had no effect on the NPo of channels containing  alone; however, BPA-MS increased 
the NPo of BK channels composed of + 1 subunits. These I-O data suggest that the 
1 subunit completes or comprises an intracellular binding site for BPA. Together, the 
data lead us to conclude that BPA activates BK channels via an extracellular binding 
site and via an intracellular binding site that depends on the presence of the 1 subunit. 
We predict that the intracellular binding site may be the same one identified for 




Cell Culture and Transfection. The techniques used here were similar to those 
we have used previously.(Asano et al., 2010) AD 293 cells (Agilent Technologies, Santa 
Clara, CA) were grown in Dulbecco's modified Eagle's medium (DMEM) supplemented 
with 10% fetal bovine serum, 100 U/ml penicillin, and 100 μg/ml streptomycin. Culture 
flasks were incubated in a 5% CO2 incubator, humidified, and kept at 37°C. Plasmids 
encoding hSlo α and hSlo α + β1 were kindly provided by Dr. Jonathan Lippiat 
(University of Leeds, Leeds, UK).(Lippiat, Standen, Harrow, Phillips, & Davies, 2003) 
Cells were transiently transfected with pIRES-hSloα or pIRES-hSloαβ1 and pmaxGFP 
(AMAXA, Gaithersburg, MD) using Lipofectamine LTX with PLUS reagent (Invitrogen, 
Carlsbad, CA). Cells at 50-70% confluence in 35-mm dishes were transfected with 0.5-
2.5 μg of DNA. Transfected cells were selected in DMEM supplemented with 0.5 mg/ml 
G418, 1% fetal bovine serum, 100 U/ml penicillin, and 100 μg/ml streptomycin. Currents 
were recorded from cells expressing green fluorescent protein (GFP) 1-3 days later. 
Electrophysiology. BK channel currents were recorded at room temperature 
from inside-out (I-O), cell-attached (C-A), and whole-cell (W-C) patches as described 
previously.(Asano et al., 2012; Asano et al., 2010) The bath flowed at a rate of 
approximately 2-3 ml/min into a into a chamber with a volume of approximately 0.2-0.3 
ml throughout the recordings. For W-C recordings, bath solution contained (mM) 135 
NaCl, 5 KCl, 2 CaCl2, 1 MgCl2, 10 glucose, 10 HEPES, and 5 Tris; pH 7.4. Chemicals 
were purchased from Fisher Scientific (Pittsburgh, PA) or Sigma-Aldrich (St. Louis, 
MO). For W-C recordings, pipette solution contained (mM) 140 KCl, 1 MgCl2, 1 EGTA, 
0.281 CaCl2, 1 Mg-ATP, 0.1 Na-GTP, 10 HEPES, and 5 Tris; pH 7.1; pCa 7. I-O and C-
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A recordings were made in symmetrical (mM) 140 KCl, 1 MgCl2, 1 EGTA, 10 HEPES, 
and 5 Tris; pH 7.1. CaCl2 was added to these solutions to achieve free Ca
2+ 
concentrations of 100 nM (pCa 7; calculated using Maxchelator; 
http://www.stanford.edu/∼cpatton/maxc.html) or 500 nM (pCa 6.3; calculated in ref 
(Bers, 1982)) as indicated for individual experiments. Because Cl- was symmetrical in all 
recording conditions, no adjustments were made for the negligible junction potentials. 
W-C and single channel pipettes were fashioned from borosilicate glass and had tip 
resistances of 2-3 and 5-10 MΩ, respectively. In W-C recordings, cell capacitance and 
series resistance were compensated as completely as possible by circuitry of the 
amplifier (Axopatch 200B; Molecular Devices, Sunnyvale, CA). Currents were low pass 
filtered at 1 kHz and digitized at 5 kHz. pClamp 9 software was used for data acquisition 
and analysis (Molecular Devices). 
Synthesis of BPA-MS. BPA-MS was synthesized from BPA and SO3-pyridinium 
complex, as described previously.(Stowell et al., 2006) BPA and 1.1 equivalents of SO3 
were stirred in dry pyridine under Ar for 36 hr. Solvent was removed under reduced 
pressure and the crude reaction mixture was purified by column chromatography (10% 
methanol in CH2Cl2). The pyridinium salt was dissolved in water and passed down a 
Dowex 50W X-8 cation exchange column, sodium form. 1H-NMR (CD3OD, 300 MHz): δ
7.18 (s, 4H), 7.02 (2H, d, J = 8.8 Hz), 6.67 (2H, d, J = 8.8 Hz), 1.6 (6H, s), 13C-NMR 
(CD3OD, 101 MHz): δ 156.2, 151.5, 149.2, 142.7, 126.7, 128.4, 121.9, 115.6, 42.8, 
31.5. ESIMS (negative ion mode) 291 (BPA-MS monoanion). 
 Statistics. Data are presented as the mean ± standard error of n number of 
patches. Current-voltage relationships were analyzed by two-way repeated measures 
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analysis of variance (2RM-ANOVA). NPo values under control conditions and with BPA-
MS and BPA stimulation (i.e., 3 values) in C-A and I-O patches were compared by one-
way repeated measures analysis of variance (1RM-ANOVA). Bonferroni post hoc tests 
followed 1RM-ANOVA and 2RM-ANOVA when appropriate to determine where 
differences existed. When only two values were compared, a paired Student’s t-test was 
used. In all tests, p < 0.05 was considered significant.  
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Figure 4.1 BPA-MS (10 M) activates BK channels in W-C patches in a 1 subunit-
dependent manner. Panel A contains families of current traces from a representative 
cell expressing BK  subunits. The voltage template is shown below; cells were held at -
80 mV and stepped from -100 to +100 mV in 20 mV increments. The addition of 10 M 
BPA-MS had no effect on current in cells expressing BK  subunits alone. Panel B 
shows group data (n = 5) illustrating the lack of effect of 10 M BPA-MS on BK 
channels composed of  only (p = 0.99 by 2RM-ANOVA). Panel C contains families of 
current traces from a representative cell expressing BK  + 1 subunits. BPA-MS (10 
M) increased current in cells expressing BK channels composed of  + 1 subunits. 
Panel D shows group data (n = 7) illustrating the increase in BK  + 1 current elicited 










Figure 4.2 A higher concentration of BPA-MS (100 M) activates current in cells 
expressing BK  subunits. Panel A contains families of current traces from a 
representative cell expressing BK  subunits. BPA-MS (100 M; note this is 10x higher 
than Fig. 1) increased current in cells expressing BK channels composed of  subunits 
only. The voltage template shown in Fig. 1 was used here also. Panel B shows group 
data (n = 7) illustrating the increase in BK  current elicited by 100 M BPA-MS 






Figure 4.3 Concentration-dependence of effects of BPA-MS.  Panel A contains data 
from a representative W-C experiment on a cell expressing BK  and  + 1. BPA-MS 
increased current in a concentration-dependent manner. Inset shows currents under 
control conditions and in the presence of 1, 10, and 100 M BPA-MS. Panel B contains 
group data for the experiment described in A (n = 9) and offers a comparison of BPA-
MS to results obtained previously with BPA in cells expressing BK  + 1 (ref. (Asano et 
al., 2010)). Further, the results from Fig. 2 are replotted here to compare effects of BPA-







Figure 4.4 BPA-MS is membrane-impermeant as shown by results in C-A patches. 
Panel A contains current traces from a representative cell expressing BK  + 1 
subunits. Currents were recorded in C-A mode in symmetrical K+ (pCa 7) at a patch 
potential of +40 mV. BPA-MS had no effect on NPo, but BPA increased NPo. Panel B 
shows group data (n = 8) illustrating the effect of BPA, but not BPA-MS, to increase NPo 
in C-A patches of BK  + 1. Asterisk indicates p < 0.05 by 1RM-ANOVA with 
Bonferroni post test. Panel C indicates that similar results were obtained using a 10-fold 







Figure 4.5 When BK channels contain 1 subunits, BPA-MS can activate from the 
cytoplasmic face of the membrane. Panel A shows a family current traces at +40 mV in 
a representative I-O patch with BK  (symmetrical 140 mM K+; pCa 6.3). The shaded 
inset shows a portion of the same current traces on an expanded time scale. Panel B 
contains group data (n = 8) and shows that 100 μM BPA-MS does not significantly 
increase the NPo of BK . In contrast, 100 μM BPA significantly increases NPo. Asterisk 
indicates p < 0.05 vs. control by 1RM-ANOVA with Bonferroni post test. Panel C shows 
a family of current traces at +40 mV from a representative I-O patch of BK α + β1 
(symmetrical 140 mM K+; pCa 7). The shaded inset shows a portion of the same traces 
on an expanded time scale. Panel D contains group data (n = 15) showing a significant 
increase in NPo elicited by BPA-MS and BPA. Asterisk indicates p < 0.05 vs. control by 
1RM-ANOVA with Bonferroni post test. Dagger indicates p < 0.05 vs. control and BPA-







Figure 4.6 BPA-MS activates BK channels containing the 1 subunit over a wide range 
of voltages. Panel A shows families of current traces from a representative I-O patch 
taken from a cell expressing BK  (symmetrical 140 mM K+; pCa 6.3). The voltage 
template is shown below. Panel B contains the I-V relationship for this single patch. 
BPA (100 M), but not BPA-MS (100 M), appears to affect current. Panel C contains 
group data (n = 8) showing that BPA-MS does not shift the midpoint (V½) of the 
activation curve. Panel D shows families of current traces from a representative I-O 
patch taken from a cell expressing BK  + 1 (symmetrical 140 mM K+; pCa 6.3). A 
slightly different voltage template is shown below. Panel E contains the I-V relationship 
for this single patch. Both BPA-MS (100 M) and BPA (100 M) appear to affect 
current. Panel F contains group data (n = 12) showing that BPA-MS and BPA both 
hyperpolarize the V½, with BPA being more effective. See text for statistical analyses of 






Figure 4.7 The effect of BPA-MS on NPo is rapid and reversible. Panel A NPo vs. time is 
plotted for a single I-O patch pulled from a cell expressing BK  + 1 (symmetrical 140 
mM K+; pCa 7; patch potential +40 mV). Cytoplasmic BPA-MS significantly activates BK 
 + 1. Washing out BPA-MS rapidly returns NPo towards baseline. Panel B shows 
current vs. time for a representative W-C experiment. Bath-applied BPA-MS increases 




Chapter 5  
General discussion 
KV1 and DPO-1 
 The regulation of arterial tone by vascular smooth muscle depends, in large part, on 
a controlled influx of extracellular Ca2+. The magnitude of this Ca2+ influx depends upon 
the efflux of intracellular K+ ions and the resulting negative membrane potential. 
Voltage-sensitive Ca2+ channels (L-type) are activated by depolarized membrane 
potential (Em); therefore, depolarization promotes Ca
2+ influx and vasoconstriction. A 
variety of K+ channels allow K+ efflux and thus oppose vasoconstriction. An unknown 
population of constitutively active K+ channels is responsible for resting arterial tone and 
maintains a polarized membrane potential that inhibits L-type Ca2+ channels. Support 
for a number of different K+ channels exists but a standout candidate remains unclear 
(see Chapter 1 for a review of putative candidates). It is our supposition that the delayed 
rectifier K+ current (KDR), specifically from the KV1 subfamily, is the main contributor to 
Em and arterial tone. 
 We used the novel KV1 antagonist diphenyl phosphine oxide-1 (DPO-1) to examine 
the effects on KDR channels in smooth muscle from three different vascular beds. DPO-
1 is reported to have a higher affinity for KV1.5 than other KV channels (Lagrutta, Wang, 
Fermini, & Salata, 2006; Regan, Wallace, Cresswell, Atkins, & Lynch, 2006; Stump, 
Wallace, Regan, & Lynch, 2005) and we demonstrated this in whole-cell patch clamp 
experiments of aortic smooth muscle cells from KV1.5 knockout mice. We investigated 
the effects of DPO-1 in rat microvessels from brain and skeletal muscle (Chapter 2) as 
well as KDR channels from porcine right coronary artery (Chapter 3). Our goals were to 
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investigate the role of KV1.5 channels in vascular smooth muscle to determine 
mechanisms of KDR channel block by DPO-1. In doing so we hope to shed light on the 
role KV1.5 may have in regulating arterial tone and reactivity. Our overall hypothesis 
was that DPO-1 inhibits KDR channels in smooth muscle cells from both resistance 
vessels and conduit arteries. Furthermore, we look to support a role for KV1.5 in 
vascular smooth muscle with regard to arterial tone in each study.  
 The MCA is a widely studied resistance vessel in the cerebral circulation with 
important physiological implications as these small arteries feed the hemispheres of the 
brain. The GA feeds the gracillis muscle and would therefore have importance 
vasoactive responses to exercise. These particular vessels were chosen from vascular 
beds with different physiological requirements to entertain the possibility of a conserved 
mechanism of resting arterial tone. In the first study (Chapter 2), we used pressure 
myography to examine the middle cerebral artery (MCA) and gracilis artery (GA) and 
their response to inhibition of KDR channels with DPO-1. We also used whole-cell patch 
clamp techniques to document effects of DPO-1 on KDR channels in smooth muscle 
cells isolated from these resistance vessels. The goal of this study was to determine a 
role for KV1.5 in vascular tone and reactivity in resistance type vessels from cerebral 
and skeletal muscle vascular beds. To accomplish that goal, we first had to identify both 
the expression of KV1.5 protein in each vessel and the specificity of DPO-1 for KV1.5 in 
our hands (i.e., with KV1.5 KO mouse experiments). Western blots confirmed the 
presence of KV1.5 protein in MCA and GA and this is in accordance with previous 
studies interested in KV channel expression in resistance vessels (Albarwani et al., 
2003; Archer et al., 1998; Archer, Weir, Reeve, & Michelakis, 2000; Cheong, Dedman, 
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& Beech, 2001; Hald et al., 2012; Kang et al., 2009; Plane et al., 2005). KV1.5 knockout 
mice had less overall current than their wild-type counterparts in whole-cell patch clamp 
of smooth muscle cells isolated from aorta. Furthermore, the DPO-1-sensitive current 
was reduced in knockout mice. We interpret this as support for our hypothesis in two 
ways: 1) KV1.5 is responsible for a significant amount of overall current in arterial 
smooth muscle and 2) DPO-1 only inhibited currents from cells that contained KV1.5. 
Because KV1.5 is expressed in MCA and GA and we confirmed the specificity of DPO-1 
for KV1.5 in arterial smooth muscle, we felt confident moving forward with using DPO-1 
to define a role for KV1.5 in regulating arterial tone in the microvasculature.  
 We determined that DPO-1 inhibits KDR by blockade of KV1.5-containing channels in 
whole-cell patch clamp of isolated smooth muscle cells from both MCA and GA. 
Previous electrophysiological recordings in atrial myocytes show DPO compounds 
preferentially block the ultra rapid activating current (IKur) produced by KV1.5 (Lagrutta 
et al., 2006; Regan et al., 2006; Stump et al., 2005). Therefore, we further support the 
use of DPO-1 as a tool to investigate KV1.5 in native cells. We also determined that 
DPO-1 affects MCA and GA tone and reactivity in a series of pressurized myograph 
experiments: 1) DPO-1 potently constricted MCA and GA at rest; 2) DPO-1 increased 
the sensitivity of MCA and GA to vasoconstrictors; 3) DPO-1 shifted the myogenic 
response of MCA and GA to decreased diameters; and 4) DPO-1 abolished 
endothelium-dependent vasodilation in MCA and GA. These data support our 
hypothesis that DPO-1 blocks KV1.5-containing KDR channels in arterial smooth muscle 
of resistance vessels and that these channels are important for vascular function. 
Furthermore, we suggest KV1.5 containing channels are open at rest and act as buffers 
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to arterial constriction and end effectors in vasodilation. In addition, we support other 
work suggesting KV1.5 channels as major contributors to resting tone and negative 
feedback against vasoconstriction in microvessels (Archer et al., 2004; Chen, 
Luykenaar, Walsh, Walsh, & Cole, 2006; Cheong et al., 2001; Gelband & Gelband, 
1997).  
 We should note, however, that while we suggest our data shows the inhibition of 
arterial smooth muscle KV1.5 channels, the abolishment of vasodilation due to Ach by 
DPO-1 might indicate inhibition of other intracellular mechanisms (i.e. inhibition of the 
sGC/cGMP/PKG pathway). It is well known that K+ channels are very important in 
mediating smooth muscle relaxation by nitric oxide (NO); however, it is also well known 
that phosphorylation status of myosin light chain kinase/phosphatase (MLCK/P) and 
intracellular Ca2+ can be influenced by membrane potential-independent cell signaling 
(Bolotina, Najibi, Palacino, Pagano, & Cohen, 1994; Khan, Mathews, & Meisheri, 1993; 
Somlyo, Wu, Walker, & Somlyo, 1999). Membrane potential-independent ligand binding 
to specific G-protein coupled receptors (GPCR) promotes cyclic nucleotide formation 
followed by direct and indirect (protein kinases) downstream activation of MLCP and/or 
inhibition of MLCK. Inhibiting these pathways physiologically or pharmacologically 
results in vasoconstriction, which is also independent of membrane potential or ion 
channel activity. This complex system of intracellular cross-talk allows for many 
regulatory pathways of vascular tone and demands careful consideration when 
investigating novel pharmacological mechanisms. Interestingly, my mentor showed that 
sodium azide (NaN3), which increases cGMP, induces vasodilation dependent on 
membrane potential yet independent of K+ channels, providing pharmaco-mechanical 
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evidence that K+ channels are not the only driving force for vasodilation, even when 
membrane potential is a factor (Swafford et al., 2005). Therefore, we cannot exclude a 
possible off target effect of DPO-1 in our studies regarding MLCK/P phosphorylation 
status, release of intracellular Ca2+ stores, or sGC/cGMP/PKG intracellular signaling in 
intact vessels independent of K+ channel inhibition. Additional pressure myograph 
experiments by which reduction of DPO-1-induced vasoconstriction by K+ channel 
independent vasodilators (NaN3, ML-7 to inhibit MLCK,  and Rho kinase inhibitors to 
prevent intracellular Ca2+ release) are required individually and in conjunction to make a 
conclusion regarding a role for KV1.5 (or other K
+ channels) in microvessel tone and 
reactivity. Should challenging intact vessels with such pharmacology not promote a 
vasodilatory effect in the presence of DPO-1, then our hypothesis that DPO-1 is a KV1.5 
specific antagonist will be refuted. If so, DPO-1 should not be used to investigate a role 
for KV1.5 in arterial tone and a new mechanism of DPO-1-induced vasoconstriction will 
be considered. We also cannot exclude inhibition of endothelial KV1.5, which we also 
predict would induce similar responses. The use of denuded microvessels and/or an NO 
donor in place of Ach in additional pressure myograph experiments will shed light on 
this issue. 
 Tentative considerations can still be made regarding a role for KV1.5 in regulating 
MCA and GA arterial tone. First, the mechanism of open state block of KV1.5 by DPO-1 
(discussed in detail in Chapter 3) is documented and indicates that channels must be 
open for DPO-1 to have an effect (Du et al., 2010; Lagrutta et al., 2006). Our data 
showing that DPO-1 constricts resistance vessels maintaining active tone suggests 
inhibition of KV1.5-containing channels open at rest. Blocking channels responsible for 
 173 
the resting Em would depolarize smooth muscle and activate L-type Ca
2+ channels, 
resulting in the observed vasoconstriction in these experiments. Second, we conclude 
that KV1.5 regulates arterial tone by opposing vasoconstriction, but does not control 
processes such as the myogenic response. This is especially evident in our data 
showing that blockade of KV1.5 by DPO-1 conserves the myogenic response at 
decreased diameters. Therefore, KDR channels prevent an exaggerated vasoconstriction 
during increased intraluminal pressures but are not responsible for myogenic behavior 
itself. We are the first to report that DPO-1 constricts intact resistance vessels from 
cerebral and skeletal muscle vascular beds and suggest that DPO-1 mediates 
vasoconstriction at rest by blocking open KV1.5 channels.  
 However, an important dichotomy should be addressed pertaining the pulmonary 
circulation and a role for KV1.5.  KV1.5 is an important oxygen sensor in the pulmonary 
vasculature as evidenced by a loss of hypoxic pulmonary vasoconstriction (HPV) during 
formation of pulmonary arterial hypertension (PAH) whereby KV1.5 expression is 
decreased. Reintroducing KV1.5 recovers HPV and ameliorates PAH (Moudgil, 
Michelakis, & Archer, 2006; Pozeg et al., 2003). The reduction in pressure and recovery 
of resting tone might indicate that KV1.5 is setting resting Em in the pulmonary 
vasculature, and many groups support this notion (Firth et al., 2009; Gelband & 
Gelband, 1997; Hong, Weir, Nelson, & Olschewski, 2004). The simultaneous recovery 
of resting tone and HPV by only reintroducing KV1.5 seemingly meets the demands of 
ventilation-perfusion matching, however, is counterintuitive to control theory. In other 
words, a single species of ion channel would be responsible for both the open 
(vasodilation due to oxygen sensing) and closed (HPV) feedback in the pulmonary 
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vasculature. It is also arguable from a physiological standpoint that KV1.5 cannot 
simultaneously set resting tone and be available for activation in an open loop fashion of 
oxygen-induced vasodilation in the absence of HPV, regardless of the oxygen control 
source (pulmonary arterial oxygen tension vs. mitochondria-derived reactive oxygen 
species) (Archer et al., 2000; Davies, Grant, Hughes, & Jones, 1973; Hughes, Grant, 
Jones, & Davies, 1974). In fact, recent evidence suggests HPV is driven by activating 
the release of intracellular Ca2+ stores via rho-kinase-dependent signaling (Aaronson et 
al., 2006; Robertson, Dipp, Ward, Aaronson, & Evans, 2000). This might be thought of 
as indirect evidence for KV1.5 in a role for setting Em in the pulmonary vasculature. 
Furthermore, in the systemic vasculature oxygen acts as a vasoconstrictor and hypoxia 
does not seemingly affect KV1.5 (Packer, Lee, Medina, & Yushak, 1986; Platoshyn et 
al., 2006; Platoshyn et al., 2001). These dichotomies support the investigation of 
vessels from different vascular beds when seeking a role for ion channels in vascular 
reactivity and tone.    
 Accordingly, the second study (Chapter 3) is an extension to our conclusion 
regarding the mechanism of DPO-1 open state block of KV1.5. Our goal in this study 
was to investigate the mechanism by which DPO-1 directly inhibits native KDR channels 
of smooth muscle cells isolated from porcine right coronary artery. We then compared 
our results to previous work examining the open state block of cloned KV1.5 by DPO-1. 
Two studies were especially useful as references regarding DPO-1 block of human 
cloned KV1.5. Lagrutta et al. described the open state block of cloned KV1.5 by DPO-1 
and showed selectivity for IKur over other K
+ currents associated with the atrial action 
potential (Lagrutta et al., 2006). Du et al. also observed open state block of cloned 
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KV1.5 by DPO-1 and showed that specific mutations in the S4 voltage-sensing segment 
reduced DPO-1-sensitive currents (Du et al., 2010). Both groups observed a time-, 
voltage-, and frequency-dependent inhibition of KV1.5 by DPO-1; hallmarks of open 
state block. Therefore, we determined the effects of DPO-1 on porcine coronary smooth 
muscle cell KDR in whole-cell patch clamp experiments similar to those performed on 
cloned KV1.5. Importantly, we also observed a time-, voltage-, and frequency-dependent 
block by DPO-1 on native smooth muscle KDR consistent with those studies on cloned 
KV1.5. However, we observed two profound differences in our study versus those 
performed on cloned KV1.5. In an open state block experiment comparable to those 
performed by Lagrutta et al., DPO-1 does not exhibit a complete open state inhibition in 
coronary smooth muscle KDR as observed in cloned KV1.5. Instead, we show that 
approximately 30-50% of the current is reduced after application of DPO-1 suggestive of 
simultaneous closed state inhibition of native smooth muscle KDR channels. 
Furthermore, the voltage of half activation of cloned KV1.5 was unaffected by DPO-1 
whereas we observed a left shift in the activation curve of smooth muscle KDR with 
application of DPO-1. We speculate that this difference may be due to the presence of 
other KV1 family subunits (e.g., KV1.2) in KV1.5-containing heterotetramers, which may 
alter effects of DPO-1 from those observed in previous studies of cloned KV1.5 
homotetramers. This idea is supported by studies that show an association of KV1.5 
with KV1.2 in vascular smooth muscle (Albarwani et al., 2003; Kerr et al., 2001). Further 
evidence of the effects of DPO-1 on KV1.5-containing heterotetramer complexes is 
required to determine if our hypothesis is supported.  
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 In addition to comparisons of cloned KV1.5, we were interested in the overall 
mechanism of arterial smooth muscle KDR channel block by DPO-1. To determine the 
mechanism of block, we analyzed a variety of whole-cell patch clamp protocols to 
extrapolate KDR channel kinetics including activation, inactivation, and recovery time 
constants (τ). DPO-1 accelerated the activation time constant suggesting that peak 
current was reached faster in the presence of DPO-1. This is a common finding with 
drugs that block KV1.5 (Jeong, Choi, & Hahn, 2013; Jeong, Choi, Yoon, & Hahn, 2012; 
Jeong, Yoon, & Hahn, 2012), but has not been shown previously with DPO-1. We also 
observed two components of inactivation τ (fast and slow) for KDR. This is most likely 
due to a number of KDR channel influences in the native system or expression of β 
auxiliary subunits such as KVβ1.3 (Plane et al., 2005), which can alter KV1.5 channel 
kinetics (Tipparaju et al., 2012; Tipparaju, Liu, Barski, & Bhatnagar, 2007). DPO-1 
robustly and significantly accelerated both τ components of inactivation. In contrast, 
DPO-1 significantly prolonged recovery from inactivation kinetics, indicating that DPO-1 
may promote the inactivated state. Interestingly, mutation of a specific residue in the S4 
voltage-sensing segment of KV1.5 mimics block by DPO-1 and reduces the sensitivity of 
the channel to DPO-1 (Du et al., 2010). Therefore, we suggest a mechanism of arterial 
smooth muscle KDR channel block whereby DPO-1 first binds residues of a KV channel 
S4 segment, not necessarily KV1.5, in the closed state. This prediction has two 
observed effects: 1) a slight increase in voltage sensitivity of the KDR channel resulting 
in a left shift of the activation curve and 2) accelerated activation kinetics i.e. the 
channel opens faster. Upon channel opening, DPO-1 may bind specific S4 segment 
residues of KV1.5 and rapidly accelerate inactivation τ components. The result is a 
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shifting of the voltage window of activation to more hyperpolarized potentials and thusly 
prevention of K+ conductance during depolarized potentials. While the voltage-
dependent block by DPO-1 in our study further supports this hypothesis, there are of 
course other possible explanations for the molecular mechanism of smooth muscle KDR 
inhibition. For instance, the effect of DPO-1 on auxiliary KVβ subunits is unknown and 
these regulatory proteins may very well play a role in the effects on kinetics and voltage 
sensitivity observed in this study. Another possible mechanism of inhibition might 
involve the intracellular T1 domain that regulates KV1.5 inactivation. Disruption of the T1 
domain results in KV1.5 inactivation type switching, specifically from P/C-type to U-type 
inactivation (Kurata, Doerksen, Eldstrom, Rezazadeh, & Fedida, 2005). DPO-1 may 
have an affinity for residues in the T1 domain and promote and prolong inactivation 
during open and inactivated states, ‘inhibiting’ KV1.5-containing channels by changing 
the inactivation type. Further investigation of cloned molecular KV machinery and the 
influence of DPO-1 on different combinations of KV1.5 containing heterotetramers with 
KVβ subunits may reveal native smooth muscle KDR composition.  
 This study expands on our work done in MCA and GA resistance vessels by 
providing a biophysical association of DPO-1 with KDR channels in native smooth 
muscle cells. Collectively, our data indicate that DPO-1 is a sufficient pharmacological 
tool to investigate native KDR channels. In conjunction with other KV1 (correolide) and 
non-KV1 (e.g. KV7 agonists and antagonists) pharmacology, DPO-1 could provide a 
clear understanding of KV1.5-containing KDR channels in arterial smooth muscle tone 
and reactivity. Importantly, this work suggests a conserved role for KV1.5 in regulating 
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arterial tone from resistance vessels in rat brain and skeletal muscle and conduit-like 
vessels of the porcine coronary circulation.  
 
BK and BPA-MS  
 
 BK channels are expressed in a variety of cell types, most notably neurons and 
vascular smooth muscle (Cox & Rusch, 2002; Sah & Faber, 2002). Tissue specific 
auxiliary BK β isoforms alter the pharmacology and biophysics of the channel 
(Contreras, Neely, Alvarez, Gonzalez, & Latorre, 2012). The β1 isoform is associated 
with vascular smooth muscle BK channels and confers activation by estrogens and 
steroid hormones (Bukiya, Liu, Toro, & Dopico, 2007; Knaus et al., 1994; Valverde et 
al., 1999). Accordingly, the estrogenic drug tamoxifen activates BK channels through 
interactions with β1 (Dick, Rossow, Smirnov, Horowitz, & Sanders, 2001). Our group 
previously showed that the xenoestrogen BPA activates BK channels in the presence 
and absence of β1, however the presence of the auxiliary subunit increased the 
sensitivity to BPA by a log order (Asano, Tune, & Dick, 2010). In Chapter 4 of this 
document we determined from which side of the membrane lipophilic BPA activates 
cloned BK channels with and without the β1 subunit. To do this we synthesized 
membrane impermeable BPA-MS and used patch clamp electrophysiology to delineate 
extracellular vs. intracellular BK channel activation by BPA. We conclude that BPA 
activates BKα from an extracellular site as BPA-MS did not activate BK in inside-out 
patches where cytoplasmic portions of the channel are exposed. Interestingly, addition 
of the β1 subunit reveals potential extracellular and intracellular activation sites. BPA-
MS did not match the efficacy of BPA on single channel open probability (NPo) in inside-
out or outside-out patches indicating that the lipophilic BPA may have multiple β1 
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activation sites. These data reflect the putative pharmacodynamics of BPA and we 
suggest activation of BK channels in vascular smooth muscle may occur during 
exposure to BPA. Whether or not this may have unwanted health deficits is uncertain. 
 The surprising findings that the β1 subunit contains an intracellular activation site 
and that BPA-MS has less effect on NPo in single channel patches suggests that 
lipophilic BPA has two β1 binding sites. Because BPA-MS is membrane impermeable it 
is possible only one activation site could be reached in patch clamp configurations.  Our 
data indicate that both β1 sites need to be bound by BPA to induce full activation of BK 
channels. Previous work conducted by my mentor shows tamoxifen, an anti-estrogen 
drug for treating breast cancer, activates BK channels via an extracellular binding site of 
the β1 subunit, and we therefore hypothesized a similar mechanism of action for BPA 
(Dick, Hunter, & Sanders, 2002). BPA-MS does activate BKα and BKα + β1 channels 
from the extracellular side, however, we also observed intracellular activation of BK 
channels similar to that of lithocholate where specific intracellular β1 residues confer BK 
activation (Bukiya et al., 2007). We predict dual activation sites on the β1 subunit for two 
reasons: 1) addition of the β1 subunit increased the sensitivity to BPA-MS by a log order 
in outside-out patches and 2) BPA-MS activated BK channels containing the β1 subunit 
from inside-out patches and did not activate BKα alone. This may have implications to 
vascular dysfunction upon exposure to BPA, as overstimulation of ion channels can 
lead to tachyphylaxis, and could very well promote the progression of diseases states 
including hypertension.  
 While circulating steroids such as lithocholate activate BK channels via the β1 
subunit, xenoestrogens such as BPA do not have an endogenous physiological role. 
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The effects of BPA must come through environmental exposure. The main route of BPA 
exposure is through the diet, although topical exposure is also possible (Porras, 
Heinala, & Santonen, 2014). In the present study, we administered micromolar 
concentrations of BPA-MS in order to see an effect on BK channels. These 
concentrations of BPA may be well above a translational concentration to daily human 
exposure, as urine concentrations of BPA were at highest 8.5 μM in factory workers 
(Wang et al., 2012). However, much lower concentrations of chronic BPA exposure alter 
the expression of ion channels (Derouiche et al., 2013; Kim, An, Yang, & Jeung, 2013). 
Here we show high concentrations of BPA activate BK channels, which may contain 
health relevance to industrial workers exposed to chronic doses at higher levels than 
the general public. 
 This study supports previous findings indicating that BPA affects ion channels in the 
cardiovascular system (Gao, Liang, Chen, & Wang, 2013; O'Reilly et al., 2012; Yan et 
al., 2011). More specifically, our group previously showed that BPA activates BK 
channels in human coronary smooth muscle cells and we expand on that knowledge 
here by showing extracellular and intracellular activation by BPA via the BKβ1 subunit 
(Asano et al., 2010). Therefore, BPA exposure may cause unwanted ion channel 
activation/inhibition in healthy persons and exacerbate preexisting disease states. While 
more information regarding the effects of BPA on BK channel function and expression 
are needed to delineate any specific pathological role, we provided a novel relationship 
for interactions with extracellular and intracellular BKβ1 residues. Furthermore, we 
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